Zakażenie mrsa
Diagnostyka i diagnoza

Zakażenie MRSA (methicillin-resistant Staphylococcus aureus) charakteryzuje się opornością na metycylinę oraz inne beta-laktamy, co wymaga precyzyjnej diagnostyki opartej na hodowli bakteryjnej, testach molekularnych (PCR, wykrywanie genu mecA, białka PBP2a) oraz szybkich metodach fenotypowych, takich jak mikrorozcieńczenie w bulionie z oksacyliną lub cefoksytyną, test dyfuzji krążkowej i hodowla na agarze z 6 µg/ml oksacyliny w podłożu Mueller-Hinton z 4% NaCl. Minimalna koncentracja hamująca (MIC) oksacyliny ≥ 4 µg/ml definiuje oporność MRSA. Diagnostyka obejmuje pobieranie próbek z nosa (preferowane miejsce kolonizacji), ran, krwi, moczu i plwociny, a także wykorzystanie nowoczesnych testów, np. cobas MRSA/SA Test i cobas vivoDx MRSA, które skracają czas uzyskania wyniku do kilku godzin. Interpretacja wyników powinna uwzględniać objawy kliniczne i różnicować kolonizację od aktywnego zakażenia, co jest kluczowe dla wdrożenia odpowiedniego leczenia i środków kontroli zakażeń w środowisku szpitalnym.

Diagnostyka zakażenia MRSA

Zakażenie MRSA (methicillin-resistant Staphylococcus aureus) to poważny rodzaj infekcji bakteryjnej wywołanej przez szczep gronkowca złocistego, który wykazuje oporność na wiele powszechnie stosowanych antybiotyków, w tym metycylinę, penicyliny, oksacylinę i amoksycylinę. Precyzyjna diagnostyka MRSA jest kluczowa dla szybkiego wdrożenia odpowiedniego leczenia oraz zapobiegania rozprzestrzenianiu się tych opornych bakterii, szczególnie w środowisku szpitalnym12.

Badania diagnostyczne w kierunku MRSA

Diagnostyka zakażenia MRSA opiera się na różnych metodach badawczych, które umożliwiają identyfikację bakterii i określenie jej oporności na antybiotyki. Podstawowe badania diagnostyczne obejmują34:

  • Pobieranie próbek z tkanek lub płynów ustrojowych z miejsca infekcji (skóra, krew, mocz, plwocina)
  • Wymazy z nosa, gardła lub ran
  • Hodowlę bakteryjną pobranych próbek
  • Badania molekularne umożliwiające wykrycie DNA bakterii

56

Standardowym testem diagnostycznym jest hodowla mikrobiologiczna, która pozwala na wzrost bakterii na specjalnych pożywkach w warunkach laboratoryjnych. Podczas badania próbka zostaje umieszczona na podłożu zawierającym składniki odżywcze sprzyjające namnażaniu bakterii. Jeśli wzrośnie Staphylococcus aureus, przeprowadzane są dodatkowe testy w celu określenia, czy szczep jest oporny na metycylinę lub inne antybiotyki78.

Szybkie metody diagnostyczne

Ponieważ tradycyjna hodowla bakteryjna wymaga około 24-48 godzin, opracowano nowsze, szybsze metody diagnostyczne9. Wśród nich najważniejsze są:

  • Reakcja łańcuchowa polimerazy (PCR) – metoda umożliwiająca wykrycie DNA bakterii MRSA w ciągu kilku godzin zamiast 48 godzin wymaganych przy hodowli. PCR jest uznawana za złoty standard w szybkiej diagnostyce MRSA1011
  • Testy molekularne – umożliwiają wykrycie genu mecA lub białka PBP2a, które są odpowiedzialne za oporność na metycylinę12
  • Chromogenne podłoża agarowe – specjalne pożywki, które zmieniają kolor w obecności MRSA, ułatwiając szybką identyfikację13
  • Testy immunochromatograficzne – pozwalają na wykrycie specyficznych antygenów bakteryjnych14

15

Firma Roche opracowała system cobas MRSA/SA Test, który wykorzystuje pojedynczy wymaz z nosa do wykrycia zarówno MRSA, jak i S. aureus w jednej próbce, dostarczając wyniki wysokiej jakości w ciągu kilku godzin16. Innym przykładem jest cobas vivoDx MRSA, który zapewnia szybką detekcję fenotypową kolonizacji MRSA poprzez bioluminescencję z wykorzystaniem nowej technologii bakteriofagowej, skracając czas diagnostyki do około 5 godzin17.

Fenotypowe metody wykrywania MRSA

Rekomendowane fenotypowe metody wykrywania MRSA obejmują18:

  • Mikrorozcieńczenie w bulionie z cefoksytyną
  • Mikrorozcieńczenie w bulionie z oksacyliną
  • Test dyfuzji krążkowej z cefoksytyną
  • Hodowlę przesiewową na agarze zawierającym 6 µg/ml oksacyliny w podłożu Mueller-Hinton wzbogaconym NaCl (4% w/v; 0,68 mol/L)

1920

Zgodnie z definicją opartą na wrażliwości na antybiotyki, oporność na metycylinę u S. aureus określa się jako minimalną koncentrację hamującą (MIC) oksacyliny większą lub równą 4 mikrogramy/ml21.

Zalecenia dotyczące pobierania próbek do badania MRSA

Prawidłowe pobranie próbki ma kluczowe znaczenie dla dokładności diagnostyki. W zależności od lokalizacji zakażenia, próbki mogą być pobierane z różnych miejsc22:

Wymaz z nosa

Preferowaną próbką do diagnostyki MRSA jest wymaz z nosa, ponieważ przednie nozdrza są najczęstszym miejscem kolonizacji23. Procedura pobrania wymazu z nosa obejmuje24:

  1. Użycie odpowiedniego podłoża transportowego (np. płynne podłoże transportowe Amies)
  2. Pobranie wymazu z obu przednich nozdrzy przy użyciu jednego wacika
  3. Wprowadzenie zwilżonego wacika na głębokość około 2 cm i obracanie go wewnątrz każdego nozdrza przez 3 sekundy, wywierając lekki nacisk z zewnętrznej strony nosa
  4. Umieszczenie wacika w plastikowej probówce transportowej i szczelne zamknięcie

25

Inne rodzaje próbek

W zależności od miejsca infekcji, mogą być pobierane również inne rodzaje próbek2627:

  • Krew – w przypadku podejrzenia bakteriemii lub ciężkich zakażeń ogólnoustrojowych
  • Wymaz z rany – przy zakażeniach skóry i tkanek miękkich
  • Plwocina – przy zakażeniach układu oddechowego
  • Mocz – w przypadku zakażeń układu moczowego
  • Wymazy z innych powierzchni skóry (pachy, okolica krocza, pachwiny) – jako alternatywne miejsca kolonizacji

2829

Interpretacja wyników badań

Interpretacja wyników badań diagnostycznych w kierunku MRSA powinna uwzględniać objawy kliniczne, wywiad medyczny oraz wyniki innych badań30.

Wyniki dodatnie i ujemne

Wynik dodatni oznacza, że wykryto bakterie MRSA w badanej próbce. Wynik ten wskazuje na zakażenie MRSA lub kolonizację, zależnie od obecności objawów klinicznych3132.

Wynik ujemny sugeruje brak MRSA w badanej próbce. Jednak brak wzrostu lub brak kolonii na podłożu CHROMagar MRSA nie wyklucza całkowicie obecności MRSA33. W przypadku silnego podejrzenia klinicznego, może być konieczne pobranie kolejnych próbek lub zastosowanie bardziej czułych metod diagnostycznych34.

Kolonizacja a zakażenie

Istotne jest rozróżnienie między kolonizacją MRSA a aktywnym zakażeniem35:

  • Kolonizacja – oznacza obecność bakterii MRSA na lub w ciele pacjenta, bez wywoływania objawów chorobowych. Pacjenci skolonizowani są nosicielami MRSA, ale nie mają objawów infekcji36
  • Zakażenie – występuje, gdy bakterie MRSA wywołują objawy chorobowe. Zakażenie MRSA jest klinicznie nieodróżnialne od zakażenia MSSA (methicillin-susceptible S. aureus), jednak ma silniejszy związek z zakażeniami szpitalnymi37

38

Czułość i swoistość testów

Testy diagnostyczne MRSA charakteryzują się różną czułością i swoistością. Na przykład, test cobas vivoDx MRSA prawidłowo identyfikuje MRSA w około 90% próbek zawierających MRSA i prawidłowo identyfikuje brak MRSA w 98,6% próbek niezawierających MRSA39.

Podłoże CHROMagar MRSA wykazuje wartości czułości i swoistości bliskie 100%, co umożliwia dokładniejsze wykrywanie MRSA niż media zawierające oksacylinę40.

Wymaz MRSA z nosa ma ujemną wartość predykcyjną (NPV) wynoszącą 99,1% w przewidywaniu przyszłych zakażeń MRSA, co sugeruje, że pacjenci z ujemnym wymazem MRSA mają bardzo niskie prawdopodobieństwo rozwoju zakażenia MRSA podczas hospitalizacji41.

Badania dodatkowe przy zakażeniach MRSA

W przypadku podejrzenia ciężkich zakażeń MRSA, szczególnie w lokalizacjach wewnętrznych, konieczne może być wykonanie dodatkowych badań obrazowych i specjalistycznych4243:

Badania obrazowe

  • Zdjęcie rentgenowskie – podstawowe badanie stosowane przy podejrzeniu zapalenia płuc wywołanego przez MRSA44
  • Tomografia komputerowa (CT) – bardziej szczegółowe badanie umożliwiające ocenę zaawansowania infekcji w tkankach, kościach i stawach45
  • Rezonans magnetyczny (MRI) – badanie pomocne w ocenie zakażeń kości, stawów i tkanek miękkich46
  • Echokardiografia – badanie zalecane u pacjentów z podejrzeniem zapalenia wsierdzia, szczególnie przy bakteriemii S. aureus4748

49

Badania laboratoryjne

Dodatkowe badania laboratoryjne mogą obejmować50:

  • Morfologię krwi – wzrost liczby białych krwinek i neutrofili wskazuje na zakażenie bakteryjne51
  • Barwienie metodą Grama – dodatni wynik barwienia z obecnością ziarniniaków w skupiskach sugeruje S. aureus52
  • Badania antybiogramowe – określające wrażliwość bakterii na różne antybiotyki, co pomaga w doborze odpowiedniego leczenia53

54

Diagnostyka różnicowa zakażeń MRSA

Zakażenia MRSA mogą być mylone z innymi schorzeniami, dlatego ważna jest diagnostyka różnicowa55:

  • Ukąszenia pająków – często mylone z zakażeniami MRSA skóry; wiele zakażeń MRSA jest błędnie diagnozowanych jako ukąszenia pająków56
  • Zakażenia wywołane przez MSSA – klinicznie nieodróżnialne od zakażeń MRSA, wymagają badań laboratoryjnych do różnicowania57
  • Inne zakażenia skóry i tkanek miękkich – ropnie, czyraki, zapalenie mieszków włosowych wywołane innymi patogenami58
  • Zmiany skórne w przebiegu boreliozy – mogą przypominać wczesne zmiany w zakażeniu MRSA59

60

Znaczenie wczesnej diagnostyki MRSA

Wczesna i dokładna diagnostyka MRSA ma kluczowe znaczenie z kilku powodów6162:

  • Umożliwia szybkie wdrożenie odpowiedniego leczenia antybiotykami, na które szczep MRSA jest wrażliwy63
  • Pozwala na zastosowanie odpowiednich środków kontroli zakażeń, zapobiegając rozprzestrzenianiu się MRSA w placówkach opieki zdrowotnej64
  • Zmniejsza ryzyko powikłań i śmiertelności związanych z zakażeniem MRSA65
  • Umożliwia racjonalne stosowanie antybiotyków, ograniczając niepotrzebne użycie leków i rozwój antybiotykooporności66

67

Badania przesiewowe MRSA

Badania przesiewowe w kierunku MRSA są istotnym elementem strategii zapobiegania i kontroli zakażeń, szczególnie w środowisku szpitalnym6869.

Wskazania do badań przesiewowych

Badania przesiewowe są zalecane w następujących sytuacjach7071:

  • Przed planowanymi zabiegami chirurgicznymi
  • Przy przyjęciu do szpitala, szczególnie na oddziały wysokiego ryzyka (np. OIT, oddział oparzeniowy)
  • U pacjentów z historią hospitalizacji w ciągu ostatnich 12 miesięcy, zwłaszcza za granicą
  • U pacjentów z czynnikami ryzyka MRSA (np. linie inwazyjne, immunosupresja)
  • U pacjentów z wywiadem wcześniejszej kolonizacji lub zakażenia MRSA

7273

Procedura badań przesiewowych

Badanie przesiewowe zwykle obejmuje74:

  • Pobieranie wymazów z nosa, gardła lub innych miejsc kolonizacji
  • Analizę próbek metodą hodowli lub technikami molekularnymi
  • Interpretację wyników i wdrożenie odpowiednich procedur w przypadku wyniku dodatniego

75

Warto podkreślić, że badanie przesiewowe MRSA ma na celu wykrycie kolonizacji i nie jest przeznaczone do diagnozowania zakażenia MRSA ani do monitorowania leczenia76.

Postępowanie po wykryciu kolonizacji

W przypadku wykrycia kolonizacji MRSA, zalecane jest7778:

  • Zastosowanie specjalnego kremu lub sprayu do nosa, środka do mycia ciała i szamponu przez około 5-10 dni w celu eliminacji MRSA
  • Wdrożenie odpowiednich środków kontroli zakażeń, w tym izolacji kontaktowej w środowisku szpitalnym
  • Ścisłe przestrzeganie higieny rąk przez personel medyczny i pacjenta
  • Monitorowanie skuteczności dekolonizacji poprzez powtarzanie badań po zakończeniu leczenia

7980

Diagnostyka a leczenie MRSA

Wyniki badań diagnostycznych mają kluczowe znaczenie dla wyboru odpowiedniego leczenia zakażeń MRSA8182.

Dobór antybiotyków na podstawie badań

Wybór antybiotyków do leczenia MRSA powinien opierać się na wynikach badań wrażliwości bakterii. Antybiotyki stosowane w leczeniu MRSA mogą obejmować8384:

  • Wankomycynę
  • Teikoplaninę
  • Linezolid
  • Daptomycynę
  • Ceftarolinę
  • Klindamycynę
  • Doksycyklinę
  • Trimetoprim-sulfametoksazol (TMP/SMX)
  • Ryfampicynę
  • Delafloksacynę

8586

Empiryczna terapia, stosowana przed uzyskaniem wyników badań diagnostycznych, powinna uwzględniać lokalne wzorce oporności S. aureus87. W przypadku ciężkich zakażeń zaleca się konsultację ze specjalistą chorób zakaźnych88.

Monitorowanie leczenia

Monitorowanie skuteczności leczenia MRSA może obejmować89:

  • Powtarzanie badań mikrobiologicznych w celu oceny eradykacji bakterii
  • Regularne badania kliniczne pacjenta w celu oceny odpowiedzi na leczenie
  • Monitorowanie stężenia terapeutycznego leków (TDM) w przypadku stosowania wankomycyny lub innych antybiotyków wymagających monitorowania stężenia

9091

Znaczenie kliniczne diagnostyki MRSA

Dokładna i szybka diagnostyka MRSA ma istotne znaczenie kliniczne i ekonomiczne9293:

  • Zmniejsza śmiertelność związaną z zakażeniami MRSA – pacjenci z zakażeniami MRSA są o 64% bardziej narażeni na śmierć niż ci z zakażeniami wrażliwymi na leki94
  • Obniża koszty leczenia poprzez ograniczenie niepotrzebnego stosowania antybiotyków i skrócenie pobytu w szpitalu95
  • Wspiera programy kontroli zakażeń, pomagając w zapobieganiu rozprzestrzeniania się MRSA w placówkach opieki zdrowotnej96
  • Umożliwia szybką izolację pacjentów kolonizowanych lub zakażonych MRSA, zapobiegając przenoszeniu bakterii na innych pacjentów97

98

Wyzwania w diagnostyce MRSA

Diagnostyka MRSA wiąże się z pewnymi wyzwaniami99:

  • Trudności w wykrywaniu oporności na oksacylinę/metycylinę ze względu na obecność dwóch subpopulacji (wrażliwej i opornej) w jednej hodowli gronkowców100
  • Czas oczekiwania na wyniki tradycyjnych hodowli bakteryjnych, co może opóźniać wdrożenie odpowiedniego leczenia101
  • Potrzeba specjalistycznego sprzętu i wyszkolonego personelu laboratoryjnego do przeprowadzania zaawansowanych badań diagnostycznych102
  • Konieczność różnicowania między kolonizacją a aktywnym zakażeniem MRSA103

104

Podsumowanie diagnostyki MRSA

Diagnostyka zakażenia MRSA wymaga kompleksowego podejścia, obejmującego ocenę kliniczną, badania laboratoryjne oraz w uzasadnionych przypadkach badania obrazowe. Szybka i dokładna diagnostyka jest kluczowa dla skutecznego leczenia i zapobiegania rozprzestrzenianiu się tego opornego patogenu105106.

Chociaż tradycyjne metody hodowlane nadal stanowią podstawę diagnostyki MRSA, coraz większą rolę odgrywają szybkie metody molekularne, takie jak PCR, które umożliwiają wykrycie bakterii w ciągu kilku godzin zamiast 24-48 godzin wymaganych przez hodowlę107.

Warto podkreślić, że szybka i dokładna diagnostyka MRSA stanowi pierwszy krok w walce z tym groźnym patogenem. Kolejne etapy obejmują odpowiednie leczenie antybiotykami, do których bakteria jest wrażliwa, oraz wdrożenie skutecznych środków kontroli zakażeń108109.

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 09.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 MRSA: Causes, Symptoms, Diagnosis, Treatment & Prevention
    https://my.clevelandclinic.org/health/diseases/11633-methicillin-resistant-staphylococcus-aureus-mrsa
    MRSA (methicillin-resistant Staphylococcus aureus) is a type of bacteria that many antibiotics dont work on. […] MRSA infections are hard to treat because very few antibiotics are effective against them. […] A healthcare provider diagnoses MRSA by sending a sample of body tissue or fluid to a lab to be tested. […] Providers treat MRSA infections by caring for open wounds and finding antibiotics that are effective against the strain of MRSA you have. […] Antibiotics a provider might use to treat MRSA include: Vancomycin, Rifampin, Trimethoprim/sulfamethoxazole (TMP/SMX), Ceftaroline, Linezolid, Daptomycin, Clindamycin, Doxycycline, Delafloxacin. […] Yes, more than half of all MRSA cases are cured with antibiotics, and providers successfully treat most MRSA skin infections.
  • #2 Methicillin-resistant Staphylococcus aureus (MRSA) Basics | MRSA | CDC
    https://www.cdc.gov/mrsa/about/index.html
    A healthcare provider must send a clinical specimen to a laboratory to determine if MRSA is the cause of an infection. […] Healthcare providers often prescribe antibiotics to treat MRSA infections. Some types of S. aureus infections need surgery to drain infected areas. Your healthcare provider will determine which treatments are best for you. While MRSA can be resistant to several antibiotics, meaning these drugs cannot cure the infections, there are antibiotics available to treat MRSA infections.
  • #3 MRSA infection – Diagnosis & treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/mrsa/diagnosis-treatment/drc-20375340
    Doctors diagnose methicillin-resistant Staphylococcus aureus (MRSA) by checking a tissue sample or nasal secretions for signs of drug-resistant bacteria. The sample is sent to a lab where it’s placed in a dish of nutrients that encourage bacterial growth. […] But because it takes about 48 hours for the bacteria to grow, newer tests that can detect staph DNA in a matter of hours are now becoming more widely available. […] During your physical exam, your doctor will closely examine any skin cuts you may have. He or she might take a sample of tissue or liquid from the cuts for testing.
  • #4 MRSA Tests: MedlinePlus Medical TestLock
    https://medlineplus.gov/lab-tests/mrsa-tests/
    A MRSA test looks for MRSA bacteria in a sample of fluid or tissue from your body. The sample is often taken from your nose or a wound. […] This test is most often used to find out if you have a MRSA infection. The test may also be used to see if treatment for a MRSA infection is working. […] You may need this test if you have symptoms of a MRSA infection. Your symptoms will depend on where the infection is located. […] A health care provider will take a fluid sample from your wound, nose, blood, or urine. […] After your test, your sample will be sent to a lab for a bacteria culture test. Most tests take 24-48 hours to get results. […] If your results are positive, it means you have a MRSA infection. Treatment will depend on how serious the infection is. […] To understand the results of a MRSA test, your provider will consider your symptoms, medical history, and the results of other tests.
  • #5 MRSA (Staph) Infection: Pictures, Symptoms, Treatment, and Prevention
    https://www.healthline.com/health/mrsa
    MRSA infections typically occur when theres a cut or break in your skin. […] Diagnosis begins with a medical history assessment and physical examination. Samples will also be taken from the site of infection. The types of samples obtained to help diagnose MRSA include the following: […] Wound samples are obtained with a sterile cotton swab and placed in a container. Theyre then taken to a laboratory to be analyzed for the presence of staph bacteria. […] A blood culture requires taking a blood draw and placing the blood on a dish in a laboratory. If bacteria grow on the dish, doctors can more easily identify what bacteria type is causing infection. […] Results from blood cultures typically take about 48 hours. A positive test result can indicate the blood infection sepsis. Bacteria can enter the blood from infections located in other parts of your body, such as the lungs, bones, and urinary tract.
  • #6 MRSA Tests: MedlinePlus Medical TestLock
    https://medlineplus.gov/lab-tests/mrsa-tests/
    A MRSA test looks for MRSA bacteria in a sample of fluid or tissue from your body. The sample is often taken from your nose or a wound. […] This test is most often used to find out if you have a MRSA infection. The test may also be used to see if treatment for a MRSA infection is working. […] You may need this test if you have symptoms of a MRSA infection. Your symptoms will depend on where the infection is located. […] A health care provider will take a fluid sample from your wound, nose, blood, or urine. […] After your test, your sample will be sent to a lab for a bacteria culture test. Most tests take 24-48 hours to get results. […] If your results are positive, it means you have a MRSA infection. Treatment will depend on how serious the infection is. […] To understand the results of a MRSA test, your provider will consider your symptoms, medical history, and the results of other tests.
  • #7 MRSA infection – Diagnosis & treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/mrsa/diagnosis-treatment/drc-20375340
    Doctors diagnose methicillin-resistant Staphylococcus aureus (MRSA) by checking a tissue sample or nasal secretions for signs of drug-resistant bacteria. The sample is sent to a lab where it’s placed in a dish of nutrients that encourage bacterial growth. […] But because it takes about 48 hours for the bacteria to grow, newer tests that can detect staph DNA in a matter of hours are now becoming more widely available. […] During your physical exam, your doctor will closely examine any skin cuts you may have. He or she might take a sample of tissue or liquid from the cuts for testing.
  • #8 MRSA Infection: Symptoms, Causes, Treatment, Contagious, Pictures & Superbug
    https://www.medicinenet.com/mrsa_infection/article.htm
    What tests do medical professionals use to diagnose a MRSA infection? […] Most doctors start with a complete history and physical exam of the patient to identify any skin changes that may be due to MRSA, especially if the patient or caretaker mentions a close association with a person who has been diagnosed with MRSA. If possible, a sample of pus from a wound, blood, or urine is sent to a microbiology lab and cultured for S. aureus. Deep infections (such as bone) may require the removal of a piece of tissue for testing (biopsy). If S. aureus is isolated (grown on a petri plate), the bacteria are then exposed to different antibiotics, including methicillin. S. aureus bacteria that grow well when methicillin is in the culture are termed MRSA, and the patient is diagnosed as MRSA-infected. Often there is no material to culture, and doctors treat the person with antibiotics that kill MRSA as well as more common bacteria until more information is available. This is called empiric therapy, meaning that doctors make their best guess on what bacteria are likely to be the cause of infection, until the bacteria have been definitively identified.
  • #9 MRSA infection – Diagnosis & treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/mrsa/diagnosis-treatment/drc-20375340
    Doctors diagnose methicillin-resistant Staphylococcus aureus (MRSA) by checking a tissue sample or nasal secretions for signs of drug-resistant bacteria. The sample is sent to a lab where it’s placed in a dish of nutrients that encourage bacterial growth. […] But because it takes about 48 hours for the bacteria to grow, newer tests that can detect staph DNA in a matter of hours are now becoming more widely available. […] During your physical exam, your doctor will closely examine any skin cuts you may have. He or she might take a sample of tissue or liquid from the cuts for testing.
  • #10 Methicillin-Resistant Staphylococcus aureus – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK482221/
    Clinical suspicion in patients with risk factors related to MRSA infection is crucial in diagnostic and therapeutic intervention. Confirmation of MRSA infection should not delay treatment with empiric antibiotics against MRSA. Clinicians should send samples from suspected sources of infection for analysis including blood, sputum, urine, or wound scraping. […] A positive Gram stain with cocci in clusters is suggestive of S. aureus. DNA polymerase chain reaction (PCR) of MRSA is the most sensitive test and gold standard test if cultures are inconclusive. DNA PCR of MRSA from nares is a frequently employed diagnostic test to rule out MRSA colonization. It is not a confirmatory test of MRSA infection, but a negative test is highly sensitive to rule out MRSA infection. […] The selection of empiric antibiotic therapy for the treatment of MRSA infection depends on the type of disease, local S. aureus resistance patterns, availability of the drug, side effect profile, and individual patient profile.
  • #11 Current molecular approach for diagnosis of MRSA: a meta-narrative review
    https://pmc.ncbi.nlm.nih.gov/articles/PMC9906022/
    The study by Senok and colleagues (2021) also reported that DNA microarray exhibited 100% specificity and sensitivity. […] Xpert MRSA/SA Blood Culture is an in vitro diagnostic test for S. aureus and MRSA. […] A study by Reddy and colleagues has shown the performance of the Xpert MRSA/SA BC assay to be 100% in specificity and sensitivity. […] MALDI-TOF mass spectrometry (MS) has become a widely used technique for the rapid and accurate identification of bacteria. […] MLST is a technique that distinguishes between isolates of bacteria species by utilizing sequences of internal fragment house-keeping genes. […] This meta-narrative review reports the commonly used molecular methods for the detection of MRSA in the past 5 years. […] In this review, multiple molecular methods such as PCR, DNA sequencing, Xpert MRSA/SA BC array, MALDI-TOF, MLST, SPA typing and SCCmec typing, have been appraised. This review summarizes that PCR technique has been widely used for the diagnosis of MRSA within the last 5 years (2017-2022). […] This meta-narrative review has appraised and summarized molecular diagnostic methods frequently used to detect MRSA in the last 5 years (2017-2022), thus concluding that PCR technique is the most frequently used technique due to its high specificity, low cost and labor effectiveness.
  • #12 Laboratory Testing for Methicillin (oxacillin)-resistant Staphylococcus aureus (MRSA) | MRSA | CDC
    https://www.cdc.gov/mrsa/php/laboratories/index.html
    There are many methods laboratorians can use to test for MRSA. […] Four phenotypic methods are recommended for the detection of MRSA. […] Accurate detection of oxacillin/methicillin resistance can be difficult due to the presence of two subpopulations (one susceptible and one resistant) that may coexist within a culture of staphylococci. […] Isolates that test positive for mecA or PBP2a or resistant by any of the recommended phenotypic methods should be reported as methicillin (oxacillin) resistant. […] Phenotypic methods recommended for the detection of MRSA include: Cefoxitin broth microdilution, Oxacillin broth microdilution, Cefoxitin disk diffusion testing. […] A screening agar containing 6 g/ml of oxacillin in Mueller-Hinton agar supplemented with NaCl (4% w/v; 0.68 mol/L) is an alternative method of testing for MRSA.
  • #13 CHROMagar™ MRSA – Chromagar
    https://www.chromagar.com/en/product/chromagar-mrsa/
    For isolation and differentiation of Methicillin Resistant Staphylococcus aureus (MRSA) […] Early detection is essential for controlling the spread of MRSA, providing appropriate care, and avoiding complex and expensive treatments. […] CHROMagar MRSA is a selective and differential chromogenic medium for the qualitative direct detection of colonization by methicillin resistant Staphylococcus aureus (MRSA) to aid in the prevention and control of MRSA in healthcare settings. […] The test is performed on anterior nares or perineal swab specimens from patients and healthcare workers to screen for MRSA colonization. […] Results can be interpreted after 18-24 h of aerobic incubation at 35-37 C. […] CHROMagar MRSA is not intended to diagnose, guide, nor monitor therapy for MRSA infections, nor provide results of susceptibility to methicillin.
  • #14 Methicillin-Resistant Staphylococcus Aureus (MRSA) – Nurseslabs
    https://nurseslabs.com/methicillin-resistant-staphylococcus-aureus-mrsa/
    Methicillin-resistant Staphylococcus aureus (MRSA) is resistant to all -lactams because of the presence of mecA, a gene that produces a pencillin binding protein (PBP2a) with low affinity for -lactam antibiotics. […] In addition to broth microdilution testing, the Clinical and Laboratory Standards Institute (CLSI), recommends the cefoxitin disk diffusion test or a plate containing 6 g/ml of oxacillin in Mueller-Hinton agar supplemented with 4% NaCl as alternative methods of testing for MRSA. […] In addition, there are FDA-approved assays for molecular detection of the mecA gene and commercially available chromogenic agars that can be used for MRSA detection. […] An alternative method for detection of MRSA is the use of anti-PBP2a monoclonal antibodies available as latex agglutination or immunochromatographic membrane assays.
  • #15 Learn About MRSA Infection: Diagnosis, Treatment, Prevention – BuzzRx
    https://www.buzzrx.com/blog/mrsa-infection
    The traditional culture and sensitivity testing takes 24-48 hours for the results to be available because the Staphylococcus aureus bacterium takes time to grow in the petri dish in the laboratory. Newer molecular tests that can detect staph DNA in a nasal swab sample within a few hours are now being increasingly used in clinical settings. […] Seek care from a healthcare professional if you have symptoms such as red, painful, swollen skin bumps accompanied by fever, especially if the symptoms do not improve within 48 hours. […] According to the Centers for Disease Control and Prevention (CDC), you cannot tell it is methicillin-resistant Staphylococcus aureus (MRSA) just by looking at the skin wound. A MRSA infection can resemble a pimple, insect bite, spider bite, cut, or scrape. […] false
  • #16 cobas® MRSA/SA Test, for use on the cobas® 4800 system
    https://diagnostics.roche.com/us/en/products/lab/cobas-mrsa-sa-test-rmd-4800-mrsasa-001.html
    Effective surveillance that enables time-saving efficiencies and lifesaving answers […] Staphylococcus aureus (SA) and methicillin-resistant Staphylococcus aureus (MRSA) infections represent a critical threat to public health. […] Conventional culture-based screening methods require sample incubation which can delay the implementation of infection control measures. […] Active surveillance to identify MRSA/SA carriers is helping to mitigate the potential consequences of disease, providing relief to patients and health care institutions facing the challenges of escalating costs. […] The cobas MRSA/SA Test for use on the cobas 4800 System uses a single nasal swab specimen to detect both MRSA and SA targets in a single sample run to deliver high quality results in a matter of hours. […] cobas MRSA/SA lets you quickly and confidently identify colonized patients for timely implementation of appropriate barrier precautions.
  • #17 Diagnostic Test for Rapid MRSA Detection Gets Market Clearance – MPR
    https://www.empr.com/home/news/diagnostic-test-for-rapid-mrsa-detection-gets-market-clearance/
    The Food and Drug Administration (FDA) has authorized marketing of a new diagnostic test, cobas vivoDx MRSA (Roche Molecular Systems Inc), to detect methicillin-resistant Staphylococcus aureus (MRSA) bacterial colonization and aid in the prevention and control of MRSA infections in healthcare settings. […] The cobas vivoDx MRSA test provides rapid phenotypic detection of MRSA colonization through bioluminescence using new bacteriophage technology. The diagnostic test allows healthcare professionals to detect MRSA from nasal swab samples in about 5 hours compared to 24-48 hours with traditional culture-based techniques. […] The FDAs authorization for marketing was based on data from performance studies reviewed through the de novo premarket regulatory pathway. Findings from the studies showed that the cobas vivoDx MRSA test correctly identified MRSA in approximately 90% of samples with MRSA present, and correctly identified no MRSA in 98.6% of samples that did not have MRSA present.
  • #18 Laboratory Testing for Methicillin (oxacillin)-resistant Staphylococcus aureus (MRSA) | MRSA | CDC
    https://www.cdc.gov/mrsa/php/laboratories/index.html
    There are many methods laboratorians can use to test for MRSA. […] Four phenotypic methods are recommended for the detection of MRSA. […] Accurate detection of oxacillin/methicillin resistance can be difficult due to the presence of two subpopulations (one susceptible and one resistant) that may coexist within a culture of staphylococci. […] Isolates that test positive for mecA or PBP2a or resistant by any of the recommended phenotypic methods should be reported as methicillin (oxacillin) resistant. […] Phenotypic methods recommended for the detection of MRSA include: Cefoxitin broth microdilution, Oxacillin broth microdilution, Cefoxitin disk diffusion testing. […] A screening agar containing 6 g/ml of oxacillin in Mueller-Hinton agar supplemented with NaCl (4% w/v; 0.68 mol/L) is an alternative method of testing for MRSA.
  • #19 Laboratory Testing for Methicillin (oxacillin)-resistant Staphylococcus aureus (MRSA) | MRSA | CDC
    https://www.cdc.gov/mrsa/php/laboratories/index.html
    There are many methods laboratorians can use to test for MRSA. […] Four phenotypic methods are recommended for the detection of MRSA. […] Accurate detection of oxacillin/methicillin resistance can be difficult due to the presence of two subpopulations (one susceptible and one resistant) that may coexist within a culture of staphylococci. […] Isolates that test positive for mecA or PBP2a or resistant by any of the recommended phenotypic methods should be reported as methicillin (oxacillin) resistant. […] Phenotypic methods recommended for the detection of MRSA include: Cefoxitin broth microdilution, Oxacillin broth microdilution, Cefoxitin disk diffusion testing. […] A screening agar containing 6 g/ml of oxacillin in Mueller-Hinton agar supplemented with NaCl (4% w/v; 0.68 mol/L) is an alternative method of testing for MRSA.
  • #20 Methicillin-Resistant Staphylococcus Aureus (MRSA) – Nurseslabs
    https://nurseslabs.com/methicillin-resistant-staphylococcus-aureus-mrsa/
    Methicillin-resistant Staphylococcus aureus (MRSA) is resistant to all -lactams because of the presence of mecA, a gene that produces a pencillin binding protein (PBP2a) with low affinity for -lactam antibiotics. […] In addition to broth microdilution testing, the Clinical and Laboratory Standards Institute (CLSI), recommends the cefoxitin disk diffusion test or a plate containing 6 g/ml of oxacillin in Mueller-Hinton agar supplemented with 4% NaCl as alternative methods of testing for MRSA. […] In addition, there are FDA-approved assays for molecular detection of the mecA gene and commercially available chromogenic agars that can be used for MRSA detection. […] An alternative method for detection of MRSA is the use of anti-PBP2a monoclonal antibodies available as latex agglutination or immunochromatographic membrane assays.
  • #21 Methicillin-Resistant Staphylococcus aureus – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK482221/
    Based on the antibiotic susceptibilities, Methicillin resistance in S. aureus is defined as an oxacillin minimum inhibitory concentration (MIC) of greater than or equal to 4 micrograms/mL. MRSA infection is one of the leading causes of hospital-acquired infections and is commonly associated with significant morbidity, mortality, length of stay, and cost burden. MRSA infections can be further divided into hospital-associated (HA-MRSA) infections and community-associated (CA-MRSA) infections. They differ not only in respect to their clinical features and molecular biology but also to their antibiotic susceptibility and treatment. This activity reviews the evaluation and management of MRSA and highlights the role of the interprofessional team in the recognition and management of this condition.
  • #22 Methicillin Resistant Staphylococcus aureus Culture Screen | Test Detail | Quest Diagnostics
    https://testdirectory.questdiagnostics.com/test/test-detail/90417/methicillin-resistant-staphylococcus-aureus-culture-screen?p=r&cc=MASTER
    Collection Instructions: 1. Use Amies liquid transport medium (red-cap Copan or BD swab), or Amies gel transport medium (blue-cap Copan or BD swab) or Eswab to obtain the specimen. 2. Culture both anterior nares (the opening of each nostril) utilizing one culture swab. 3. Insert a premoistened swab (sterile non-bacteriostatic saline or water) about 2 cm and rotate the swab against the nasal mucosa back and forth of each nostril for 3 seconds – slight pressure with a finger on the outside of the nose helps to assure good contact between the swab and the inside of the nose. 4. Return swab back to the plastic transport tube and make sure the cap is on tight. […] Transport Container: Swab in Amies culture media, Eswab or equivalent […] Transport Temperature: Room temperature […] Specimen Stability: Room temperature: 48 hours, Refrigerated: 48 hours, Frozen: Unacceptable […] Reject Criteria: Received frozen • Specimens submitted in formalin • Specimens submitted in viral transport media • Dry swabs • Expired transport media • Specimens >48 hours old • Swabs from environmental sources.
  • #23 MRSA: diagnosis, screening and management – The Pharmaceutical Journal
    https://pharmaceutical-journal.com/article/ld/mrsa-diagnosis-screening-and-management
    MRSA: diagnosis, screening and management […] Prevention is therefore important to reduce the impact on patient outcomes and length of hospital stays, and healthcare professionals should understand the diagnosis, screening, and management of MRSA-colonised and MRSA-infected patients. […] MRSA colonisation is detected through microbiological screening. […] Microbiological screening often involves nasal screening because the anterior nares are the most frequently colonised site. […] To detect MRSA, a clinical sample must be taken from the patient and sent to the laboratory. […] MRSA infection is clinically indistinguishable from MSSA (methicillin-susceptible S. aureus) infection, however, it has a stronger association with hospital-acquired infections than MSSA and case fatality ratios tend to be higher for MRSA bacteraemia compared with MSSA bacteraemia.
  • #24 Methicillin Resistant Staphylococcus aureus Culture Screen | Test Detail | Quest Diagnostics
    https://testdirectory.questdiagnostics.com/test/test-detail/90417/methicillin-resistant-staphylococcus-aureus-culture-screen?p=r&cc=MASTER
    Collection Instructions: 1. Use Amies liquid transport medium (red-cap Copan or BD swab), or Amies gel transport medium (blue-cap Copan or BD swab) or Eswab to obtain the specimen. 2. Culture both anterior nares (the opening of each nostril) utilizing one culture swab. 3. Insert a premoistened swab (sterile non-bacteriostatic saline or water) about 2 cm and rotate the swab against the nasal mucosa back and forth of each nostril for 3 seconds – slight pressure with a finger on the outside of the nose helps to assure good contact between the swab and the inside of the nose. 4. Return swab back to the plastic transport tube and make sure the cap is on tight. […] Transport Container: Swab in Amies culture media, Eswab or equivalent […] Transport Temperature: Room temperature […] Specimen Stability: Room temperature: 48 hours, Refrigerated: 48 hours, Frozen: Unacceptable […] Reject Criteria: Received frozen • Specimens submitted in formalin • Specimens submitted in viral transport media • Dry swabs • Expired transport media • Specimens >48 hours old • Swabs from environmental sources.
  • #25 Methicillin Resistant Staphylococcus aureus Culture Screen | Test Detail | Quest Diagnostics
    https://testdirectory.questdiagnostics.com/test/test-detail/90417/methicillin-resistant-staphylococcus-aureus-culture-screen?p=r&cc=MASTER
    Collection Instructions: 1. Use Amies liquid transport medium (red-cap Copan or BD swab), or Amies gel transport medium (blue-cap Copan or BD swab) or Eswab to obtain the specimen. 2. Culture both anterior nares (the opening of each nostril) utilizing one culture swab. 3. Insert a premoistened swab (sterile non-bacteriostatic saline or water) about 2 cm and rotate the swab against the nasal mucosa back and forth of each nostril for 3 seconds – slight pressure with a finger on the outside of the nose helps to assure good contact between the swab and the inside of the nose. 4. Return swab back to the plastic transport tube and make sure the cap is on tight. […] Transport Container: Swab in Amies culture media, Eswab or equivalent […] Transport Temperature: Room temperature […] Specimen Stability: Room temperature: 48 hours, Refrigerated: 48 hours, Frozen: Unacceptable […] Reject Criteria: Received frozen • Specimens submitted in formalin • Specimens submitted in viral transport media • Dry swabs • Expired transport media • Specimens >48 hours old • Swabs from environmental sources.
  • #26 MRSA Tests: MedlinePlus Medical TestLock
    https://medlineplus.gov/lab-tests/mrsa-tests/
    A MRSA test looks for MRSA bacteria in a sample of fluid or tissue from your body. The sample is often taken from your nose or a wound. […] This test is most often used to find out if you have a MRSA infection. The test may also be used to see if treatment for a MRSA infection is working. […] You may need this test if you have symptoms of a MRSA infection. Your symptoms will depend on where the infection is located. […] A health care provider will take a fluid sample from your wound, nose, blood, or urine. […] After your test, your sample will be sent to a lab for a bacteria culture test. Most tests take 24-48 hours to get results. […] If your results are positive, it means you have a MRSA infection. Treatment will depend on how serious the infection is. […] To understand the results of a MRSA test, your provider will consider your symptoms, medical history, and the results of other tests.
  • #27 MRSA: Symptoms, Causes, Treatments, and Your Risk
    https://www.webmd.com/skin-problems-and-treatments/understanding-mrsa
    MRSA Testing […] Testing to find out whether you have MRSA will vary depending on where the infection site is. To diagnose the problem, your doctor may take samples from different parts of your body. They may take samples of your: […] Blood […] Urine […] Sputum (mucus coughed up from your lungs) […] Tissue from a wound […] A skin or nasal swab […] Then, your doctor will send the samples to a lab to be tested for signs of drug-resistant bacteria. […] […] […] MRSA Treatment […] The treatment that you need depends on what kind of infection you have and where it is. For example, it may be limited to a skin infection, or the bacteria may have entered your bloodstream. […] Treatment may include: […] Draining fluid from an abscess […] Surgically removing tissue thats infected
  • #28 Methicillin Resistant Staphylococcus aureus Culture Screen | Test Detail | Quest Diagnostics
    https://testdirectory.questdiagnostics.com/test/test-detail/90417/methicillin-resistant-staphylococcus-aureus-culture-screen?p=r&cc=MASTER
    Collection Instructions: 1. Use Amies liquid transport medium (red-cap Copan or BD swab), or Amies gel transport medium (blue-cap Copan or BD swab) or Eswab to obtain the specimen. 2. Culture both anterior nares (the opening of each nostril) utilizing one culture swab. 3. Insert a premoistened swab (sterile non-bacteriostatic saline or water) about 2 cm and rotate the swab against the nasal mucosa back and forth of each nostril for 3 seconds – slight pressure with a finger on the outside of the nose helps to assure good contact between the swab and the inside of the nose. 4. Return swab back to the plastic transport tube and make sure the cap is on tight. […] Transport Container: Swab in Amies culture media, Eswab or equivalent […] Transport Temperature: Room temperature […] Specimen Stability: Room temperature: 48 hours, Refrigerated: 48 hours, Frozen: Unacceptable […] Reject Criteria: Received frozen • Specimens submitted in formalin • Specimens submitted in viral transport media • Dry swabs • Expired transport media • Specimens >48 hours old • Swabs from environmental sources.
  • #29 Learning about MRSA: A guide for Patients – MN Dept. of Health
    https://www.health.state.mn.us/diseases/staph/mrsa/book.html
    Many people with active infections are treated effectively, and no longer have MRSA. […] However, sometimes MRSA goes away after treatment and comes back several times. […] If MRSA infections keep coming back again and again, your doctor can help you figure out the reasons you keep getting them. […] If you have ever had an active MRSA infection or you are a carrier, you should tell your health care providers. […] You would not usually be tested for MRSA unless you have an active infection. […] If you have a skin infection, your doctor may take a sample of the area to find out what bacteria is causing your infection. This is called taking a culture. […] The lab will then test the bacteria to find out which antibiotic is best for you. […] If your MRSA infections keep coming back again and again, your doctor may test you and your family members to see if you are carriers. […] In this case, the doctor would take a culture from the nose or other areas where MRSA can be found.
  • #30 MRSA Tests: MedlinePlus Medical TestLock
    https://medlineplus.gov/lab-tests/mrsa-tests/
    A MRSA test looks for MRSA bacteria in a sample of fluid or tissue from your body. The sample is often taken from your nose or a wound. […] This test is most often used to find out if you have a MRSA infection. The test may also be used to see if treatment for a MRSA infection is working. […] You may need this test if you have symptoms of a MRSA infection. Your symptoms will depend on where the infection is located. […] A health care provider will take a fluid sample from your wound, nose, blood, or urine. […] After your test, your sample will be sent to a lab for a bacteria culture test. Most tests take 24-48 hours to get results. […] If your results are positive, it means you have a MRSA infection. Treatment will depend on how serious the infection is. […] To understand the results of a MRSA test, your provider will consider your symptoms, medical history, and the results of other tests.
  • #31 MRSA Tests: MedlinePlus Medical TestLock
    https://medlineplus.gov/lab-tests/mrsa-tests/
    A MRSA test looks for MRSA bacteria in a sample of fluid or tissue from your body. The sample is often taken from your nose or a wound. […] This test is most often used to find out if you have a MRSA infection. The test may also be used to see if treatment for a MRSA infection is working. […] You may need this test if you have symptoms of a MRSA infection. Your symptoms will depend on where the infection is located. […] A health care provider will take a fluid sample from your wound, nose, blood, or urine. […] After your test, your sample will be sent to a lab for a bacteria culture test. Most tests take 24-48 hours to get results. […] If your results are positive, it means you have a MRSA infection. Treatment will depend on how serious the infection is. […] To understand the results of a MRSA test, your provider will consider your symptoms, medical history, and the results of other tests.
  • #32 MRSA Screening: Candidates, Procedure, Results, and Next Steps
    https://www.healthline.com/health/mrsa-screening
    MRSA screening is a low risk procedure used to determine whether you have MRSA on your skin or a MRSA infection. Antibiotic treatments are available if you test positive. […] MRSA screening allows doctors to quickly detect and begin appropriate treatment for those with MRSA infections. […] MRSA screening is the diagnostic testing doctors use to determine whether MRSA is present on or in a persons body. Its also known as MRSA testing. […] MRSA screening can be used to see if you have a MRSA infection and whether treatments are working. […] If you receive a positive MRSA test result, you have MRSA on or in your body. […] If you have a positive test result and are showing signs of infection, its important to start treatment quickly. […] MRSA screening is low risk, and testing samples can be collected through swabs, blood draws, or urine. Antibiotic treatments are available for those whose results come back positive.
  • #33 CHROMagar™ MRSA – Chromagar
    https://www.chromagar.com/en/product/chromagar-mrsa/
    A lack of growth or the absence of pink colonies on CHROMagar MRSA does not preclude the presence of MRSA. […] Further identification, susceptibility testing, and epidemiological typing is needed on suspect colonies. […] CHROMagar MRSA can also be used in conjunction with other laboratory tests and clinical data available to aid in the identification and in the diagnosis of MRSA infections in skin, soft tissue, wounds and positive blood cultures. […] Concomitant cultures are necessary to recover organisms for further microbiological susceptibility testing or epidemiological typing. […] 1. Absolutely reliable: CHROMagar MRSA, introduced in 2002, was the first chromogenic medium for MRSA detection. […] 2. Efficient: The medium exhibits sensitivity and specificity values close to 100 %. […] CHROMagar MRSA allows an accurate detection of MRSA with a higher level of sensitivity than oxacillin containing media. […] 3. Fast easy interpretation: Intense mauve colony colour in 18-24 h.
  • #34 MRSA SWAB AS A PREDICTOR OF MRSA INFECTION – SHM Abstracts | Society of Hospital Medicine
    https://shmabstracts.org/abstract/mrsa-swab-as-a-predictor-of-mrsa-infection/
    Septic patients that require ICU level of care are treated empirically with vancomycin. […] A test to identify patients with a low risk for MRSA infection could facilitate early vancomycin discontinuation. […] In patients presenting with pneumonia, MRSA swabs have been shown to have a negative predictive value (NPV) of 94-97% for the diagnosis of MRSA pneumonia. […] The overall positive predictive value (PPV) of MRSA swabs in predicting future MRSA cultures was 8.1% and negative predictive value (NPV) was 99.1% (95% CI 98.1 to 99.6). […] The NPV of 99% for MRSA swabs in this population suggests that critically ill septic patients presenting with a negative MRSA swab are very unlikely to be diagnosed with a MRSA infections during their hospitalization. […] This high NPV is consistent with other studies and supports the utility of MRSA swabs in identifying patients for early de-escalation of MRSA coverage. […] The results of this study indicate that such de-escalation may be applicable to other infectious sources as well.
  • #35 Methicillin-resistant Staphylococcus aureus (MRSA) – Symptoms, diagnosis and treatment | BMJ Best Practice
    https://bestpractice.bmj.com/topics/en-gb/910
    MRSA is an important cause of infection in both healthy people in the community and in patients in healthcare institutions. […] It is important to distinguish MRSA colonisation from infection. […] Healthcare-associated MRSA infections and community-associated MRSA infections exhibit important differences in antibiotic susceptibility. […] Community-associated MRSA most commonly results in skin and soft-tissue infections and therapy can often be with oral antibiotics. […] Healthcare-associated MRSA infections usually require treatment with intravenous antibiotics. […] Isolation of patients with MRSA, through contact precautions, may help to prevent spread of infection. […] MRSA infections can include syndromes of bacteraemia, pneumonia, endocarditis, joint infections, and skin or soft-tissue infections.
  • #36 MRSA Testing | Patient Education | UCSF Health
    https://www.ucsfhealth.org/education/mrsa-testing
    California state law requires hospitals to test some patients for a germ called methicillin-resistant Staphylococcus aureus, or MRSA. If you’re admitted to the hospital at UCSF Medical Center for surgery and you’re considered susceptible for MRSA infection, you will be tested for this germ. […] If your MRSA test is positive, you are considered „colonized” with MRSA. Being colonized simply means that at the moment your nose was swabbed, MRSA was present. If the test is negative, it means you aren’t colonized with MRSA. […] In most cases, being colonized with MRSA doesn’t make you sick and no treatment is necessary. If you have an infection, your doctor will treat it. Treatments may include draining the sores or taking antibiotics. […] Routine cleaning of your hands and environment is the best way to prevent your infection from spreading to others. […] If you’re given antibiotics, take all of them, even if your symptoms improve. If your infection doesn’t improve within several days, call your doctor.
  • #37 MRSA: diagnosis, screening and management – The Pharmaceutical Journal
    https://pharmaceutical-journal.com/article/ld/mrsa-diagnosis-screening-and-management
    MRSA: diagnosis, screening and management […] Prevention is therefore important to reduce the impact on patient outcomes and length of hospital stays, and healthcare professionals should understand the diagnosis, screening, and management of MRSA-colonised and MRSA-infected patients. […] MRSA colonisation is detected through microbiological screening. […] Microbiological screening often involves nasal screening because the anterior nares are the most frequently colonised site. […] To detect MRSA, a clinical sample must be taken from the patient and sent to the laboratory. […] MRSA infection is clinically indistinguishable from MSSA (methicillin-susceptible S. aureus) infection, however, it has a stronger association with hospital-acquired infections than MSSA and case fatality ratios tend to be higher for MRSA bacteraemia compared with MSSA bacteraemia.
  • #38 Three Tidbits for Better MRSA Dx Reporting – AAPC Knowledge Center
    https://www.aapc.com/blog/37426-three-tidbits-for-better-mrsa-dx-reporting/?srsltid=AfmBOoocOA9Tlm_vmw3Cwp5O-EcBAj-P2iv7qKccJVGctaNYTqSc0S50
    J15.212 Pneumonia due to Methicillin resistant Staphylococcus aureus. […] Other sequencing exceptions include MRSA in obstetrical or neonatal coding, for which you are instructed to report the source of infection as an additional code. […] Many conditions require you to report MRSA with B95.62, and a second code to identify the site/type of infection, such as the skin site or specific heart valve. […] The drug resistance is inherent in the MRSA code, and ICD-10-CM guidelines tell you to leave Z16.11 out. […] A person who has been colonized has MRSA present, without necessarily having an active MRSA infection. […] Patients undergoing hospitalization or outpatient elective surgery usually are tested for colonization using a nasal swab. […] If MRSA is found, documentation may read MRSA screen positive or MRSA swab positive.
  • #39 Diagnostic Test for Rapid MRSA Detection Gets Market Clearance – MPR
    https://www.empr.com/home/news/diagnostic-test-for-rapid-mrsa-detection-gets-market-clearance/
    The Food and Drug Administration (FDA) has authorized marketing of a new diagnostic test, cobas vivoDx MRSA (Roche Molecular Systems Inc), to detect methicillin-resistant Staphylococcus aureus (MRSA) bacterial colonization and aid in the prevention and control of MRSA infections in healthcare settings. […] The cobas vivoDx MRSA test provides rapid phenotypic detection of MRSA colonization through bioluminescence using new bacteriophage technology. The diagnostic test allows healthcare professionals to detect MRSA from nasal swab samples in about 5 hours compared to 24-48 hours with traditional culture-based techniques. […] The FDAs authorization for marketing was based on data from performance studies reviewed through the de novo premarket regulatory pathway. Findings from the studies showed that the cobas vivoDx MRSA test correctly identified MRSA in approximately 90% of samples with MRSA present, and correctly identified no MRSA in 98.6% of samples that did not have MRSA present.
  • #40 CHROMagar™ MRSA – Chromagar
    https://www.chromagar.com/en/product/chromagar-mrsa/
    A lack of growth or the absence of pink colonies on CHROMagar MRSA does not preclude the presence of MRSA. […] Further identification, susceptibility testing, and epidemiological typing is needed on suspect colonies. […] CHROMagar MRSA can also be used in conjunction with other laboratory tests and clinical data available to aid in the identification and in the diagnosis of MRSA infections in skin, soft tissue, wounds and positive blood cultures. […] Concomitant cultures are necessary to recover organisms for further microbiological susceptibility testing or epidemiological typing. […] 1. Absolutely reliable: CHROMagar MRSA, introduced in 2002, was the first chromogenic medium for MRSA detection. […] 2. Efficient: The medium exhibits sensitivity and specificity values close to 100 %. […] CHROMagar MRSA allows an accurate detection of MRSA with a higher level of sensitivity than oxacillin containing media. […] 3. Fast easy interpretation: Intense mauve colony colour in 18-24 h.
  • #41 MRSA SWAB AS A PREDICTOR OF MRSA INFECTION – SHM Abstracts | Society of Hospital Medicine
    https://shmabstracts.org/abstract/mrsa-swab-as-a-predictor-of-mrsa-infection/
    Septic patients that require ICU level of care are treated empirically with vancomycin. […] A test to identify patients with a low risk for MRSA infection could facilitate early vancomycin discontinuation. […] In patients presenting with pneumonia, MRSA swabs have been shown to have a negative predictive value (NPV) of 94-97% for the diagnosis of MRSA pneumonia. […] The overall positive predictive value (PPV) of MRSA swabs in predicting future MRSA cultures was 8.1% and negative predictive value (NPV) was 99.1% (95% CI 98.1 to 99.6). […] The NPV of 99% for MRSA swabs in this population suggests that critically ill septic patients presenting with a negative MRSA swab are very unlikely to be diagnosed with a MRSA infections during their hospitalization. […] This high NPV is consistent with other studies and supports the utility of MRSA swabs in identifying patients for early de-escalation of MRSA coverage. […] The results of this study indicate that such de-escalation may be applicable to other infectious sources as well.
  • #42 Patient education: Methicillin-resistant Staphylococcus aureus (MRSA) (Beyond the Basics) – UpToDate
    https://www.uptodate.com/contents/methicillin-resistant-staphylococcus-aureus-mrsa-beyond-the-basics
    Patient education: Methicillin-resistant Staphylococcus aureus (MRSA) (Beyond the Basics) […] This topic review discusses the signs and symptoms, diagnostic tests, treatment, and prevention of a particularly dangerous form of Staph aureus called methicillin-resistant Staphylococcus aureus (MRSA; pronounced „Mursa”). […] MRSA DIAGNOSIS […] People with skin infections can be tested for MRSA with a culture. Results of the test are usually available in 24 to 72 hours. […] People with infections of the lung, bone, joint, or other internal areas usually require blood tests as well as imaging studies (eg, X-ray, computed tomography [CT] scan, echocardiogram).
  • #43 Patient education: Methicillin-resistant Staphylococcus aureus (MRSA) (Beyond the Basics) – UpToDate
    https://www.uptodate.com/contents/methicillin-resistant-staphylococcus-aureus-mrsa-beyond-the-basics/print
    This topic review discusses the signs and symptoms, diagnostic tests, treatment, and prevention of a particularly dangerous form of Staph aureus called methicillin-resistant Staphylococcus aureus (MRSA; pronounced „Mursa”). […] People with skin infections can be tested for MRSA with a culture. Results of the test are usually available in 24 to 72 hours. […] People with infections of the lung, bone, joint, or other internal areas usually require blood tests as well as imaging studies (eg, X-ray, computed tomography [CT] scan, echocardiogram).
  • #44 MRSA Infection | Valley Children’s Healthcare
    https://www.valleychildrens.org/services/infectious-disease/conditions-we-treat/mrsa-infection
    MRSA infection can be harder to treat than other staph bacteria, but there are oral and IV (intravenous) antibiotics that can successfully treat it. […] The healthcare provider will ask about your child’s symptoms and health history. They will give your child a physical exam. Your child may also have tests, such as: […] A skin swab, to check for MRSA […] Cultures from samples of blood, spit, or fluid from a sore, to check for MRSA […] X-ray of the lungs, to see if the lungs may be infected […] Echocardiogram of the heart, if MRSA has entered the bloodstream. This test is to see if a heart valve may be infected. […] Targeted CT scan or MRI scan, to see if any other tissue, bones, or joints are infected. […] If your child has a mild MRSA skin infection, the healthcare provider will likely treat it by opening the infected sore and draining out the fluid (pus). You might be given a prescription antibiotic ointment to use on your child. Your child might need to take antibiotic medicine by mouth. […] Don’t try to treat a MRSA infection on your own. This can spread the infection to other people or make it worse for your child. Cover the infected area, wash your hands, and call your child’s healthcare provider.
  • #45 MRSA Infection | Valley Children’s Healthcare
    https://www.valleychildrens.org/services/infectious-disease/conditions-we-treat/mrsa-infection
    MRSA infection can be harder to treat than other staph bacteria, but there are oral and IV (intravenous) antibiotics that can successfully treat it. […] The healthcare provider will ask about your child’s symptoms and health history. They will give your child a physical exam. Your child may also have tests, such as: […] A skin swab, to check for MRSA […] Cultures from samples of blood, spit, or fluid from a sore, to check for MRSA […] X-ray of the lungs, to see if the lungs may be infected […] Echocardiogram of the heart, if MRSA has entered the bloodstream. This test is to see if a heart valve may be infected. […] Targeted CT scan or MRI scan, to see if any other tissue, bones, or joints are infected. […] If your child has a mild MRSA skin infection, the healthcare provider will likely treat it by opening the infected sore and draining out the fluid (pus). You might be given a prescription antibiotic ointment to use on your child. Your child might need to take antibiotic medicine by mouth. […] Don’t try to treat a MRSA infection on your own. This can spread the infection to other people or make it worse for your child. Cover the infected area, wash your hands, and call your child’s healthcare provider.
  • #46 MRSA Infection | Valley Children’s Healthcare
    https://www.valleychildrens.org/services/infectious-disease/conditions-we-treat/mrsa-infection
    MRSA infection can be harder to treat than other staph bacteria, but there are oral and IV (intravenous) antibiotics that can successfully treat it. […] The healthcare provider will ask about your child’s symptoms and health history. They will give your child a physical exam. Your child may also have tests, such as: […] A skin swab, to check for MRSA […] Cultures from samples of blood, spit, or fluid from a sore, to check for MRSA […] X-ray of the lungs, to see if the lungs may be infected […] Echocardiogram of the heart, if MRSA has entered the bloodstream. This test is to see if a heart valve may be infected. […] Targeted CT scan or MRI scan, to see if any other tissue, bones, or joints are infected. […] If your child has a mild MRSA skin infection, the healthcare provider will likely treat it by opening the infected sore and draining out the fluid (pus). You might be given a prescription antibiotic ointment to use on your child. Your child might need to take antibiotic medicine by mouth. […] Don’t try to treat a MRSA infection on your own. This can spread the infection to other people or make it worse for your child. Cover the infected area, wash your hands, and call your child’s healthcare provider.
  • #47 MRSA Infection | Valley Children’s Healthcare
    https://www.valleychildrens.org/services/infectious-disease/conditions-we-treat/mrsa-infection
    MRSA infection can be harder to treat than other staph bacteria, but there are oral and IV (intravenous) antibiotics that can successfully treat it. […] The healthcare provider will ask about your child’s symptoms and health history. They will give your child a physical exam. Your child may also have tests, such as: […] A skin swab, to check for MRSA […] Cultures from samples of blood, spit, or fluid from a sore, to check for MRSA […] X-ray of the lungs, to see if the lungs may be infected […] Echocardiogram of the heart, if MRSA has entered the bloodstream. This test is to see if a heart valve may be infected. […] Targeted CT scan or MRI scan, to see if any other tissue, bones, or joints are infected. […] If your child has a mild MRSA skin infection, the healthcare provider will likely treat it by opening the infected sore and draining out the fluid (pus). You might be given a prescription antibiotic ointment to use on your child. Your child might need to take antibiotic medicine by mouth. […] Don’t try to treat a MRSA infection on your own. This can spread the infection to other people or make it worse for your child. Cover the infected area, wash your hands, and call your child’s healthcare provider.
  • #48 MRSA: Nursing Diagnoses, Care Plans, Assessment & Interventions | NurseTogether
    https://www.nursetogether.com/mrsa-nursing-diagnosis-care-plan/
    A standard diagnostic procedure to screen for MRSA colonization is DNA PCR of MRSA from the nares. […] Clinicians should send blood, sputum, urine, or wound samples suspected to be the source of infection for analysis. […] Patients suspected of having S. aureus bacteremia should undergo echocardiography or transesophageal echocardiography (TEE) to rule out endocarditis. […] If untreated or undertreated, MRSA can worsen into sepsis. […] If infection symptoms don’t improve within a few days of taking the prescribed antibiotic, advise the patient to call their healthcare provider. […] Patients at risk for MRSA infection (transfer from LTC facility/prison, invasive lines, immunosuppression) or with a history of MRSA should be screened for MRSA via nasal swabbing. […] Increasing WBC and neutrophil counts indicate bacterial infection. S. aureus appears as gram-positive cocci in clusters in gram staining. If cultures are inconclusive, DNA PCR is the gold standard and most sensitive test to identify MRSA.
  • #49 Staphylococcus aureus Infections – Infections – Merck Manual Consumer Version
    https://www.merckmanuals.com/home/infections/bacterial-infections-gram-positive-bacteria/staphylococcus-aureus-infections
    The diagnosis is based on the appearance of the skin or identification of the bacteria in a sample of the infected material. […] Other infections require samples of blood or infected fluids, which are sent to a laboratory to grow (culture), identify, and test the bacteria. Laboratory results confirm the diagnosis and determine which antibiotics can kill the staphylococci (called susceptibility testing). […] If a doctor suspects osteomyelitis, x-rays, computed tomography (CT), magnetic resonance imaging (MRI), radionuclide bone scanning, or a combination is also done. These tests can show where the damage is and help determine how severe it is. […] Staphylococcal skin infections are usually diagnosed based on their appearance. […] Infections due to Staphylococcus aureus are treated with antibiotics. Doctors try to determine whether the bacteria are resistant to antibiotics and, if so, to which antibiotics.
  • #50 MRSA: Nursing Diagnoses, Care Plans, Assessment & Interventions | NurseTogether
    https://www.nursetogether.com/mrsa-nursing-diagnosis-care-plan/
    A standard diagnostic procedure to screen for MRSA colonization is DNA PCR of MRSA from the nares. […] Clinicians should send blood, sputum, urine, or wound samples suspected to be the source of infection for analysis. […] Patients suspected of having S. aureus bacteremia should undergo echocardiography or transesophageal echocardiography (TEE) to rule out endocarditis. […] If untreated or undertreated, MRSA can worsen into sepsis. […] If infection symptoms don’t improve within a few days of taking the prescribed antibiotic, advise the patient to call their healthcare provider. […] Patients at risk for MRSA infection (transfer from LTC facility/prison, invasive lines, immunosuppression) or with a history of MRSA should be screened for MRSA via nasal swabbing. […] Increasing WBC and neutrophil counts indicate bacterial infection. S. aureus appears as gram-positive cocci in clusters in gram staining. If cultures are inconclusive, DNA PCR is the gold standard and most sensitive test to identify MRSA.
  • #51 MRSA: Nursing Diagnoses, Care Plans, Assessment & Interventions | NurseTogether
    https://www.nursetogether.com/mrsa-nursing-diagnosis-care-plan/
    A standard diagnostic procedure to screen for MRSA colonization is DNA PCR of MRSA from the nares. […] Clinicians should send blood, sputum, urine, or wound samples suspected to be the source of infection for analysis. […] Patients suspected of having S. aureus bacteremia should undergo echocardiography or transesophageal echocardiography (TEE) to rule out endocarditis. […] If untreated or undertreated, MRSA can worsen into sepsis. […] If infection symptoms don’t improve within a few days of taking the prescribed antibiotic, advise the patient to call their healthcare provider. […] Patients at risk for MRSA infection (transfer from LTC facility/prison, invasive lines, immunosuppression) or with a history of MRSA should be screened for MRSA via nasal swabbing. […] Increasing WBC and neutrophil counts indicate bacterial infection. S. aureus appears as gram-positive cocci in clusters in gram staining. If cultures are inconclusive, DNA PCR is the gold standard and most sensitive test to identify MRSA.
  • #52 Methicillin-Resistant Staphylococcus aureus – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK482221/
    Clinical suspicion in patients with risk factors related to MRSA infection is crucial in diagnostic and therapeutic intervention. Confirmation of MRSA infection should not delay treatment with empiric antibiotics against MRSA. Clinicians should send samples from suspected sources of infection for analysis including blood, sputum, urine, or wound scraping. […] A positive Gram stain with cocci in clusters is suggestive of S. aureus. DNA polymerase chain reaction (PCR) of MRSA is the most sensitive test and gold standard test if cultures are inconclusive. DNA PCR of MRSA from nares is a frequently employed diagnostic test to rule out MRSA colonization. It is not a confirmatory test of MRSA infection, but a negative test is highly sensitive to rule out MRSA infection. […] The selection of empiric antibiotic therapy for the treatment of MRSA infection depends on the type of disease, local S. aureus resistance patterns, availability of the drug, side effect profile, and individual patient profile.
  • #53 Diagnosing Antibiotic-Resistant Infections | NYU Langone Health
    https://nyulangone.org/conditions/antibiotic-resistant-infections/diagnosis
    Specialists in a laboratory expose the bacteria in the sample to different antibiotics. If the bacteria continue to grow, they are thought to be resistant to the medications. If they are destroyed, they are susceptible to the antibiotics, and your doctor can then prescribe one or more medications to manage the infection.
  • #54 MRSA Infection: Symptoms, Causes, Treatment, Contagious, Pictures & Superbug
    https://www.medicinenet.com/mrsa_infection/article.htm
    Some hospitals may screen patients for carrying MRSA so that precautions can be taken to avoid spreading MRSA. The same procedure is done by swabbing the skin or inside the nose. These tests help distinguish MRSA infections from other skin changes that often appear initially similar to MRSA, such as spider bites or skin changes that occur with Lyme disease. Many MRSA infections get mistaken for a spider bite. This can cause delayed or incorrect treatment and progression of the MRSA infection. […] There are rapid screening tests that can detect the presence of MRSA DNA material (polymerase chain reaction, PCR) in a blood sample in as little as two hours. The test is able to determine whether the genetic material is from MRSA or from less resistant forms of staph bacteria. It may allow hospitals to start precautions early. It may also allow doctors to quickly tailor the antibiotics to only what is needed; this reduces unnecessary antibiotic use and helps reduce antibiotic resistance. It also may reduce the side effects and costs of unnecessary antibiotics. These tests cannot be used alone for the diagnosis of an MRSA infection. They do not provide important details about the antibiotics to which the specific strain is susceptible.
  • #55 MRSA Infection: Symptoms, Causes, Treatment, Contagious, Pictures & Superbug
    https://www.medicinenet.com/mrsa_infection/article.htm
    Some hospitals may screen patients for carrying MRSA so that precautions can be taken to avoid spreading MRSA. The same procedure is done by swabbing the skin or inside the nose. These tests help distinguish MRSA infections from other skin changes that often appear initially similar to MRSA, such as spider bites or skin changes that occur with Lyme disease. Many MRSA infections get mistaken for a spider bite. This can cause delayed or incorrect treatment and progression of the MRSA infection. […] There are rapid screening tests that can detect the presence of MRSA DNA material (polymerase chain reaction, PCR) in a blood sample in as little as two hours. The test is able to determine whether the genetic material is from MRSA or from less resistant forms of staph bacteria. It may allow hospitals to start precautions early. It may also allow doctors to quickly tailor the antibiotics to only what is needed; this reduces unnecessary antibiotic use and helps reduce antibiotic resistance. It also may reduce the side effects and costs of unnecessary antibiotics. These tests cannot be used alone for the diagnosis of an MRSA infection. They do not provide important details about the antibiotics to which the specific strain is susceptible.
  • #56 MRSA Infection: Symptoms, Causes, Treatment, Contagious, Pictures & Superbug
    https://www.medicinenet.com/mrsa_infection/article.htm
    Some hospitals may screen patients for carrying MRSA so that precautions can be taken to avoid spreading MRSA. The same procedure is done by swabbing the skin or inside the nose. These tests help distinguish MRSA infections from other skin changes that often appear initially similar to MRSA, such as spider bites or skin changes that occur with Lyme disease. Many MRSA infections get mistaken for a spider bite. This can cause delayed or incorrect treatment and progression of the MRSA infection. […] There are rapid screening tests that can detect the presence of MRSA DNA material (polymerase chain reaction, PCR) in a blood sample in as little as two hours. The test is able to determine whether the genetic material is from MRSA or from less resistant forms of staph bacteria. It may allow hospitals to start precautions early. It may also allow doctors to quickly tailor the antibiotics to only what is needed; this reduces unnecessary antibiotic use and helps reduce antibiotic resistance. It also may reduce the side effects and costs of unnecessary antibiotics. These tests cannot be used alone for the diagnosis of an MRSA infection. They do not provide important details about the antibiotics to which the specific strain is susceptible.
  • #57 MRSA: diagnosis, screening and management – The Pharmaceutical Journal
    https://pharmaceutical-journal.com/article/ld/mrsa-diagnosis-screening-and-management
    MRSA: diagnosis, screening and management […] Prevention is therefore important to reduce the impact on patient outcomes and length of hospital stays, and healthcare professionals should understand the diagnosis, screening, and management of MRSA-colonised and MRSA-infected patients. […] MRSA colonisation is detected through microbiological screening. […] Microbiological screening often involves nasal screening because the anterior nares are the most frequently colonised site. […] To detect MRSA, a clinical sample must be taken from the patient and sent to the laboratory. […] MRSA infection is clinically indistinguishable from MSSA (methicillin-susceptible S. aureus) infection, however, it has a stronger association with hospital-acquired infections than MSSA and case fatality ratios tend to be higher for MRSA bacteraemia compared with MSSA bacteraemia.
  • #58 Methicillin-Resistant Staphylococcus Aureus (MRSA) – Nurseslabs
    https://nurseslabs.com/methicillin-resistant-staphylococcus-aureus-mrsa/
    CDC encourages clinicians to consider MRSA in the differential diagnosis of skin and soft tissue infections (SSTIs) compatible with S. aureus infections, especially those that are purulent (fluctuant or palpable fluid-filled cavity, yellow or white center, central point or head, draining pus, or possible to aspirate pus with needle or syringe).
  • #59 MRSA Infection: Symptoms, Causes, Treatment, Contagious, Pictures & Superbug
    https://www.medicinenet.com/mrsa_infection/article.htm
    Some hospitals may screen patients for carrying MRSA so that precautions can be taken to avoid spreading MRSA. The same procedure is done by swabbing the skin or inside the nose. These tests help distinguish MRSA infections from other skin changes that often appear initially similar to MRSA, such as spider bites or skin changes that occur with Lyme disease. Many MRSA infections get mistaken for a spider bite. This can cause delayed or incorrect treatment and progression of the MRSA infection. […] There are rapid screening tests that can detect the presence of MRSA DNA material (polymerase chain reaction, PCR) in a blood sample in as little as two hours. The test is able to determine whether the genetic material is from MRSA or from less resistant forms of staph bacteria. It may allow hospitals to start precautions early. It may also allow doctors to quickly tailor the antibiotics to only what is needed; this reduces unnecessary antibiotic use and helps reduce antibiotic resistance. It also may reduce the side effects and costs of unnecessary antibiotics. These tests cannot be used alone for the diagnosis of an MRSA infection. They do not provide important details about the antibiotics to which the specific strain is susceptible.
  • #60 Methicillin-resistant Staphylococcus aureus (MRSA) – Diversey
    https://www.solutionsdesignedforhealthcare.com/methicillin-resistant-staphylococcus-aureus-mrsa-prevention/
    It should be included in the differential diagnosis of skin and soft tissue infections (SSTIs) compatible with S. aureus infections, especially those that are purulent (fluctuant or palpable fluid-filled cavity, yellow or white center, central point or head, draining pus, or possible to aspirate pus with needle or syringe). A patient presenting a complaint of a spider bite should raise suspicion of a S.aureus infection. Recent data suggest that infection in the community is increasing. The spectrum of disease caused by MRSA appears to be similar to that of Staphylococcus aureus in the community. SSTIs, specifically furuncles (abscessed hair follicles or boils), carbuncles (coalesced masses of furuncles), and abscesses, are the most frequently reported clinical manifestations. […] In general, a culture should be obtained from the infection site and sent to the microbiology laboratory. If S. aureus is isolated, the organism should be tested to determine which antibiotics will be effective for treating the infection. […] A culture of a skin lesion is especially useful in recurrent or persistent cases of skin infection, in cases of antibiotic failure, and in cases that present with advanced or aggressive infections.
  • #61 Failure to Diagnose a MRSA Infection | Baltimore Medical Malpractice Lawyers
    https://www.arfaalawgroup.com/medical-negligence-and-personal-injury/medical-malpractice/failure-to-diagnose-or-treat-misdiagnosis/failure-to-diagnose-a-mrsa-infection/
    MRSA infections can be deadly, and a patients prognosis depends, in part, on the timeliness of their diagnosis. […] In most instances, laboratory tests are needed to determine if a person has MRSA or another infection. […] MRSA infections require urgent care, and delays can be fatal. Thus, people who suffer losses due to a doctors failure to diagnose a MRSA infection will often seek compensation in a medical malpractice lawsuit. […] The failure to diagnose a MRSA infection can have life-altering consequences.
  • #62 Methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus aureus (SA)
    https://diagnostics.roche.com/global/en/article-listing/health-topics/infectious-diseases/mrsa.html
    Prompt diagnosis and treatment are of utmost importance. […] The substantial human suffering and financial burden of these endemic infections prompt an urgent need for healthcare facilities to establish effective surveillance for infection control and prevention. […] To address the evolving problem of MRSA/SA, growing numbers of hospitals are partnering with microbiology labs to incorporate MRSA/SA screening and surveillance to identify and control these infections. […] Microbiology labs are the first lines of defence for detection of MRSA/SA unexpected outbreaks. By implementing a reliable surveillance program that rapidly and accurately detects colonised patients, clinical microbiology and infection control can help reduce the worldwide burden and spread of these costly infections.
  • #63 MRSA: Causes, Symptoms, Diagnosis, Treatment & Prevention
    https://my.clevelandclinic.org/health/diseases/11633-methicillin-resistant-staphylococcus-aureus-mrsa
    MRSA (methicillin-resistant Staphylococcus aureus) is a type of bacteria that many antibiotics dont work on. […] MRSA infections are hard to treat because very few antibiotics are effective against them. […] A healthcare provider diagnoses MRSA by sending a sample of body tissue or fluid to a lab to be tested. […] Providers treat MRSA infections by caring for open wounds and finding antibiotics that are effective against the strain of MRSA you have. […] Antibiotics a provider might use to treat MRSA include: Vancomycin, Rifampin, Trimethoprim/sulfamethoxazole (TMP/SMX), Ceftaroline, Linezolid, Daptomycin, Clindamycin, Doxycycline, Delafloxacin. […] Yes, more than half of all MRSA cases are cured with antibiotics, and providers successfully treat most MRSA skin infections.
  • #64 MRSA Surgical Site Infections: What You Should Know | bioMérieux Living Diagnostics Blog
    https://www.biomerieux.com/us/en/blog/infectious-diseases/MRSA-surgical-site-infections.html
    In low- and middle-income countries, 11% of patients who undergo surgery are infected in the process. […] However, with antimicrobial resistance on the rise, many infections are becoming more and more difficult to treat. MRSA, or methicillin-resistant Staphylococcus aureus, is a type of S. aureus that has become resistant to many first-line antibiotics and it commonly infects surgical wounds. […] The World Health Organization reports that patients with MRSA infections are 64% more likely to die than those with drug-sensitive infections. […] MRSA in healthcare settings can lead to a number of severe issues including surgical site infections, blood stream infections, sepsis, and even death. […] Overall, MRSA infections in hospitalized patients are declining, but they can still be difficult to treat. MRSA infections are preventable and many lives have been saved through effective infection control interventions. […] However, MRSA is resistant to currently-available beta-lactam antibiotics, which includes penicillins, such as amoxicillin, anti-staphylococcal penicillins, such as methicillin, and cephalosporins.
  • #65 MRSA Surgical Site Infections: What You Should Know | bioMérieux Living Diagnostics Blog
    https://www.biomerieux.com/us/en/blog/infectious-diseases/MRSA-surgical-site-infections.html
    In low- and middle-income countries, 11% of patients who undergo surgery are infected in the process. […] However, with antimicrobial resistance on the rise, many infections are becoming more and more difficult to treat. MRSA, or methicillin-resistant Staphylococcus aureus, is a type of S. aureus that has become resistant to many first-line antibiotics and it commonly infects surgical wounds. […] The World Health Organization reports that patients with MRSA infections are 64% more likely to die than those with drug-sensitive infections. […] MRSA in healthcare settings can lead to a number of severe issues including surgical site infections, blood stream infections, sepsis, and even death. […] Overall, MRSA infections in hospitalized patients are declining, but they can still be difficult to treat. MRSA infections are preventable and many lives have been saved through effective infection control interventions. […] However, MRSA is resistant to currently-available beta-lactam antibiotics, which includes penicillins, such as amoxicillin, anti-staphylococcal penicillins, such as methicillin, and cephalosporins.
  • #66 MRSA Infection: Symptoms, Causes, Treatment, Contagious, Pictures & Superbug
    https://www.medicinenet.com/mrsa_infection/article.htm
    Some hospitals may screen patients for carrying MRSA so that precautions can be taken to avoid spreading MRSA. The same procedure is done by swabbing the skin or inside the nose. These tests help distinguish MRSA infections from other skin changes that often appear initially similar to MRSA, such as spider bites or skin changes that occur with Lyme disease. Many MRSA infections get mistaken for a spider bite. This can cause delayed or incorrect treatment and progression of the MRSA infection. […] There are rapid screening tests that can detect the presence of MRSA DNA material (polymerase chain reaction, PCR) in a blood sample in as little as two hours. The test is able to determine whether the genetic material is from MRSA or from less resistant forms of staph bacteria. It may allow hospitals to start precautions early. It may also allow doctors to quickly tailor the antibiotics to only what is needed; this reduces unnecessary antibiotic use and helps reduce antibiotic resistance. It also may reduce the side effects and costs of unnecessary antibiotics. These tests cannot be used alone for the diagnosis of an MRSA infection. They do not provide important details about the antibiotics to which the specific strain is susceptible.
  • #67 CHROMagar™ MRSA – Chromagar
    https://www.chromagar.com/en/product/chromagar-mrsa/
    For isolation and differentiation of Methicillin Resistant Staphylococcus aureus (MRSA) […] Early detection is essential for controlling the spread of MRSA, providing appropriate care, and avoiding complex and expensive treatments. […] CHROMagar MRSA is a selective and differential chromogenic medium for the qualitative direct detection of colonization by methicillin resistant Staphylococcus aureus (MRSA) to aid in the prevention and control of MRSA in healthcare settings. […] The test is performed on anterior nares or perineal swab specimens from patients and healthcare workers to screen for MRSA colonization. […] Results can be interpreted after 18-24 h of aerobic incubation at 35-37 C. […] CHROMagar MRSA is not intended to diagnose, guide, nor monitor therapy for MRSA infections, nor provide results of susceptibility to methicillin.
  • #68 MRSA: diagnosis, screening and management – The Pharmaceutical Journal
    https://pharmaceutical-journal.com/article/ld/mrsa-diagnosis-screening-and-management
    MRSA: diagnosis, screening and management […] Prevention is therefore important to reduce the impact on patient outcomes and length of hospital stays, and healthcare professionals should understand the diagnosis, screening, and management of MRSA-colonised and MRSA-infected patients. […] MRSA colonisation is detected through microbiological screening. […] Microbiological screening often involves nasal screening because the anterior nares are the most frequently colonised site. […] To detect MRSA, a clinical sample must be taken from the patient and sent to the laboratory. […] MRSA infection is clinically indistinguishable from MSSA (methicillin-susceptible S. aureus) infection, however, it has a stronger association with hospital-acquired infections than MSSA and case fatality ratios tend to be higher for MRSA bacteraemia compared with MSSA bacteraemia.
  • #69 MRSA Screening: Candidates, Procedure, Results, and Next Steps
    https://www.healthline.com/health/mrsa-screening
    MRSA screening is a low risk procedure used to determine whether you have MRSA on your skin or a MRSA infection. Antibiotic treatments are available if you test positive. […] MRSA screening allows doctors to quickly detect and begin appropriate treatment for those with MRSA infections. […] MRSA screening is the diagnostic testing doctors use to determine whether MRSA is present on or in a persons body. Its also known as MRSA testing. […] MRSA screening can be used to see if you have a MRSA infection and whether treatments are working. […] If you receive a positive MRSA test result, you have MRSA on or in your body. […] If you have a positive test result and are showing signs of infection, its important to start treatment quickly. […] MRSA screening is low risk, and testing samples can be collected through swabs, blood draws, or urine. Antibiotic treatments are available for those whose results come back positive.
  • #70 MRSA
    https://www.nhs.uk/conditions/mrsa/
    MRSA can be treated with antibiotics. […] Antibiotic tablets can be used for mild MRSA infections. […] More serious infections may need to be treated in hospital with antibiotics given by injection or a drip into a vein in your arm. […] If you’re due to have surgery, you may be offered a screening test for MRSA before you go into hospital. […] The swabs are then sent for testing. […] If the result shows you have MRSA on your skin, you’ll need to treat it with a special nasal cream or spray, body wash and shampoo for around 5 to 10 days.
  • #71 MRSA (methicillin resistant staphylococcus aureus)
    https://www.healthywa.wa.gov.au/Articles/J_M/MRSA
    MRSA infections can occur among people in hospitals and other healthcare facilities, like residential aged care. […] Screening patients for MRSA is an important way to prevent or stop outbreaks in healthcare facilities and keep patients safe. […] If someone has a history of being in a hospital overseas or outside of Western Australia (WA) in the last 12 months or residential care facility, a specimen to look for MRSA (swab from your nose and throat and/or any wounds/lesions on your skin) will be collected when you are admitted to hospital. […] MRSA infections are treated with antibiotics. Your doctor should take a swab of the infected site to make sure the right antibiotics are given. […] After you have finished the treatment, swabs to test for MRSA should be taken to check if you are still carrying the bacteria. […] Remember to tell your healthcare provider you have MRSA.
  • #72 MRSA: Nursing Diagnoses, Care Plans, Assessment & Interventions | NurseTogether
    https://www.nursetogether.com/mrsa-nursing-diagnosis-care-plan/
    A standard diagnostic procedure to screen for MRSA colonization is DNA PCR of MRSA from the nares. […] Clinicians should send blood, sputum, urine, or wound samples suspected to be the source of infection for analysis. […] Patients suspected of having S. aureus bacteremia should undergo echocardiography or transesophageal echocardiography (TEE) to rule out endocarditis. […] If untreated or undertreated, MRSA can worsen into sepsis. […] If infection symptoms don’t improve within a few days of taking the prescribed antibiotic, advise the patient to call their healthcare provider. […] Patients at risk for MRSA infection (transfer from LTC facility/prison, invasive lines, immunosuppression) or with a history of MRSA should be screened for MRSA via nasal swabbing. […] Increasing WBC and neutrophil counts indicate bacterial infection. S. aureus appears as gram-positive cocci in clusters in gram staining. If cultures are inconclusive, DNA PCR is the gold standard and most sensitive test to identify MRSA.
  • #73 Three Tidbits for Better MRSA Dx Reporting – AAPC Knowledge Center
    https://www.aapc.com/blog/37426-three-tidbits-for-better-mrsa-dx-reporting/?srsltid=AfmBOoocOA9Tlm_vmw3Cwp5O-EcBAj-P2iv7qKccJVGctaNYTqSc0S50
    J15.212 Pneumonia due to Methicillin resistant Staphylococcus aureus. […] Other sequencing exceptions include MRSA in obstetrical or neonatal coding, for which you are instructed to report the source of infection as an additional code. […] Many conditions require you to report MRSA with B95.62, and a second code to identify the site/type of infection, such as the skin site or specific heart valve. […] The drug resistance is inherent in the MRSA code, and ICD-10-CM guidelines tell you to leave Z16.11 out. […] A person who has been colonized has MRSA present, without necessarily having an active MRSA infection. […] Patients undergoing hospitalization or outpatient elective surgery usually are tested for colonization using a nasal swab. […] If MRSA is found, documentation may read MRSA screen positive or MRSA swab positive.
  • #74 Methicillin Resistant Staphylococcus aureus Culture Screen | Test Detail | Quest Diagnostics
    https://testdirectory.questdiagnostics.com/test/test-detail/90417/methicillin-resistant-staphylococcus-aureus-culture-screen?p=r&cc=MASTER
    Methicillin Resistant Staphylococcus aureus Culture Screen – MRSA is a major cause of nosocomial and life threatening infections. Infections with MRSA have been associated with a significantly high morbidity, mortality and cost. Selection of these organisms has been greatest in the healthcare setting. However, MRSA has also become more prevalent in the community. To control the transmission of MRSA, the Society for Healthcare Epidemiology of America (SHEA) has recommended guidelines, which include an active surveillance to identify potential reservoirs and a rigorous infection control program to control the spread of MRSA. […] Methodology: Chrom Agar method […] Reference Range(s): No Methicillin Resistant Staphylococcus aureus (MRSA) isolated. […] Preferred Specimen(s): Nasal swab […] Alternative Specimen(s): Specimens from skin surfaces „non-wound” (i.e. axilla, perianal and groin)
  • #75 183467: Methicillin-resistant Staphylococcus aureus (MRSA) Colonization Screening Culture | Labcorp
    https://www.labcorp.com/tests/183467/methicillin-resistant-staphylococcus-aureus-mrsa-colonization-screening-culture
    Screen for methicillin-resistant Staphylococcus aureus (MRSA) colonization of patients and staff in health care settings […] This test is intended only for screening for MRSA colonization and is not intended to diagnose MRSA infection or to guide or monitor treatment for infections. […] This test is not intended to establish diagnosis of MRSA infection.
  • #76 183467: Methicillin-resistant Staphylococcus aureus (MRSA) Colonization Screening Culture | Labcorp
    https://www.labcorp.com/tests/183467/methicillin-resistant-staphylococcus-aureus-mrsa-colonization-screening-culture
    Screen for methicillin-resistant Staphylococcus aureus (MRSA) colonization of patients and staff in health care settings […] This test is intended only for screening for MRSA colonization and is not intended to diagnose MRSA infection or to guide or monitor treatment for infections. […] This test is not intended to establish diagnosis of MRSA infection.
  • #77 MRSA
    https://www.nhs.uk/conditions/mrsa/
    MRSA can be treated with antibiotics. […] Antibiotic tablets can be used for mild MRSA infections. […] More serious infections may need to be treated in hospital with antibiotics given by injection or a drip into a vein in your arm. […] If you’re due to have surgery, you may be offered a screening test for MRSA before you go into hospital. […] The swabs are then sent for testing. […] If the result shows you have MRSA on your skin, you’ll need to treat it with a special nasal cream or spray, body wash and shampoo for around 5 to 10 days.
  • #78 MRSA Action UK | Symptoms
    http://mrsaactionuk.net/symptoms.html
    MRSA infections are diagnosed by testing blood, urine or a sample of tissue from the infected area for the presence of MRSA bacteria. If MRSA bacteria are found, further tests will be done to see which antibiotics the bacteria do not have resistance to, and so which can be used to treat them. […] Many hospitals now test or screen patients who are being admitted to see if they are carrying MRSA. Swabs from the skin and nose, urine and blood samples may be tested for the bacteria. It can take 3-5 days for the results to come back. More information is available on our screening for MRSA page. […] If you are colonised with MRSA you may still be admitted, but doctors will give you treatment to reduce or remove the MRSA bacteria.
  • #79 MRSA Infection in the Community (Methicillin Resistant Staphylococcus Aureus)
    https://www.nationwidechildrens.org/conditions/staphylococcus-aureus-skin-infections-in-the-community
    After your child is diagnosed with MRSA, the diagnosis will stay in his or her medical record until these things are done: Your child needs to be out of the hospital and off antimicrobial therapy and invasive devices for six months. Then: A Culture MRSA Screen (MRSAC) test to check for active MRSA needs to be ordered by your child’s pediatrician. This test can be done at your child’s pediatrician’s office during a routine visit, at a Nationwide Children’s Hospitals Urgent Care, or scheduled by the parents at a Nationwide Children’s Hospitals test center they choose. […] If the original diagnosis was from a respiratory infection, there need to be three cultures taken from the nose. All three need to test negative for Multidrug-Resistant Organisms (MDROs). These cultures need to be taken at least 72 hours apart with no hospitalization, off antimicrobial therapy and no invasive devices in between.
  • #80 MRSA Infection in the Community (Methicillin Resistant Staphylococcus Aureus)
    https://www.nationwidechildrens.org/conditions/staphylococcus-aureus-skin-infections-in-the-community
    If the original diagnosis was from a non-respiratory site (wound, drainage, blood urine, etc.), there need to be three cultures from the nose and three from the rectum that test negative for MDROs. These cultures need to be taken at least 72 hours apart with no hospitalization, off antimicrobial therapy and no invasive devices in between.
  • #81 MRSA Tests: MedlinePlus Medical TestLock
    https://medlineplus.gov/lab-tests/mrsa-tests/
    A MRSA test looks for MRSA bacteria in a sample of fluid or tissue from your body. The sample is often taken from your nose or a wound. […] This test is most often used to find out if you have a MRSA infection. The test may also be used to see if treatment for a MRSA infection is working. […] You may need this test if you have symptoms of a MRSA infection. Your symptoms will depend on where the infection is located. […] A health care provider will take a fluid sample from your wound, nose, blood, or urine. […] After your test, your sample will be sent to a lab for a bacteria culture test. Most tests take 24-48 hours to get results. […] If your results are positive, it means you have a MRSA infection. Treatment will depend on how serious the infection is. […] To understand the results of a MRSA test, your provider will consider your symptoms, medical history, and the results of other tests.
  • #82 MRSA: diagnosis, screening and management – The Pharmaceutical Journal
    https://pharmaceutical-journal.com/article/ld/mrsa-diagnosis-screening-and-management
    Depending on the clinical infection syndrome suspected and the severity of clinical illness, empirical antibiotics may be started based on local microbiological guidelines for the suspected syndrome. […] In patients known to be colonised with MRSA or thought to be at high risk of MRSA infection, clinicians may opt for antibiotics that cover MRSA prior to receiving any culture/sensitivity results. […] MRSA decolonisation is not routinely required for asymptomatic carriers of MRSA in the community. […] Antibiotic prophylaxis should be given to patients undergoing any surgery that is not defined as ‘clean non-prosthetic uncomplicated surgery’, according to NICE guidelines. […] Vancomycin and teicoplanin (both given parenterally) remain the antibiotics of choice for treatment of MRSA infection.
  • #83 MRSA: Causes, Symptoms, Diagnosis, Treatment & Prevention
    https://my.clevelandclinic.org/health/diseases/11633-methicillin-resistant-staphylococcus-aureus-mrsa
    MRSA (methicillin-resistant Staphylococcus aureus) is a type of bacteria that many antibiotics dont work on. […] MRSA infections are hard to treat because very few antibiotics are effective against them. […] A healthcare provider diagnoses MRSA by sending a sample of body tissue or fluid to a lab to be tested. […] Providers treat MRSA infections by caring for open wounds and finding antibiotics that are effective against the strain of MRSA you have. […] Antibiotics a provider might use to treat MRSA include: Vancomycin, Rifampin, Trimethoprim/sulfamethoxazole (TMP/SMX), Ceftaroline, Linezolid, Daptomycin, Clindamycin, Doxycycline, Delafloxacin. […] Yes, more than half of all MRSA cases are cured with antibiotics, and providers successfully treat most MRSA skin infections.
  • #84 MRSA: diagnosis, screening and management – The Pharmaceutical Journal
    https://pharmaceutical-journal.com/article/ld/mrsa-diagnosis-screening-and-management
    Depending on the clinical infection syndrome suspected and the severity of clinical illness, empirical antibiotics may be started based on local microbiological guidelines for the suspected syndrome. […] In patients known to be colonised with MRSA or thought to be at high risk of MRSA infection, clinicians may opt for antibiotics that cover MRSA prior to receiving any culture/sensitivity results. […] MRSA decolonisation is not routinely required for asymptomatic carriers of MRSA in the community. […] Antibiotic prophylaxis should be given to patients undergoing any surgery that is not defined as ‘clean non-prosthetic uncomplicated surgery’, according to NICE guidelines. […] Vancomycin and teicoplanin (both given parenterally) remain the antibiotics of choice for treatment of MRSA infection.
  • #85 MRSA: Causes, Symptoms, Diagnosis, Treatment & Prevention
    https://my.clevelandclinic.org/health/diseases/11633-methicillin-resistant-staphylococcus-aureus-mrsa
    MRSA (methicillin-resistant Staphylococcus aureus) is a type of bacteria that many antibiotics dont work on. […] MRSA infections are hard to treat because very few antibiotics are effective against them. […] A healthcare provider diagnoses MRSA by sending a sample of body tissue or fluid to a lab to be tested. […] Providers treat MRSA infections by caring for open wounds and finding antibiotics that are effective against the strain of MRSA you have. […] Antibiotics a provider might use to treat MRSA include: Vancomycin, Rifampin, Trimethoprim/sulfamethoxazole (TMP/SMX), Ceftaroline, Linezolid, Daptomycin, Clindamycin, Doxycycline, Delafloxacin. […] Yes, more than half of all MRSA cases are cured with antibiotics, and providers successfully treat most MRSA skin infections.
  • #86 Staphylococcus aureus Infections – Infections – Merck Manual Consumer Version
    https://www.merckmanuals.com/home/infections/bacterial-infections-gram-positive-bacteria/staphylococcus-aureus-infections
    MRSA infection can be acquired outside of a health care facility. The community-acquired MRSA strains are usually susceptible to other antibiotics, such as trimethoprim/sulfamethoxazole, clindamycin, minocycline, or doxycycline, as well as to the antibiotics used to treat MRSA infections acquired in the hospital. […] Mild skin infections due to MRSA, such as folliculitis, are usually treated with an ointment, such as one that contains bacitracin, neomycin, and polymyxin B (available without a prescription) or mupirocin (available by prescription only). If more than an ointment is required, antibiotics effective against MRSA are given by mouth or intravenously. […] If an infection involves bone or foreign material in the body (such as heart pacemakers, artificial heart valves and joints, and blood vessel grafts), rifampin and possibly another antibiotic are sometimes added to the antibiotic regimen. Usually, infected bone and foreign material has to be removed surgically to cure the infection. […] Abscesses, if present, are usually drained.
  • #87 Methicillin-Resistant Staphylococcus aureus – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK482221/
    Clinical suspicion in patients with risk factors related to MRSA infection is crucial in diagnostic and therapeutic intervention. Confirmation of MRSA infection should not delay treatment with empiric antibiotics against MRSA. Clinicians should send samples from suspected sources of infection for analysis including blood, sputum, urine, or wound scraping. […] A positive Gram stain with cocci in clusters is suggestive of S. aureus. DNA polymerase chain reaction (PCR) of MRSA is the most sensitive test and gold standard test if cultures are inconclusive. DNA PCR of MRSA from nares is a frequently employed diagnostic test to rule out MRSA colonization. It is not a confirmatory test of MRSA infection, but a negative test is highly sensitive to rule out MRSA infection. […] The selection of empiric antibiotic therapy for the treatment of MRSA infection depends on the type of disease, local S. aureus resistance patterns, availability of the drug, side effect profile, and individual patient profile.
  • #88 MRSA Infection – St. Michael’s Elite Hospital
    https://24hrer.com/mrsa-infection/
    MRSA infection is a type of staph infection that can cause skin infections and other problems. MRSA stands for methicillin-resistant Staphylococcus aureus, which means it is resistant to antibiotics called beta-lactams such as penicillin and amoxicillin. MRSA spreads easily in the community and healthcare settings. […] MRSA infections should be treated by a doctor. The majority of treatment options are determined by the severity of the infection and the bacteria’s resistance pattern. […] Many doctors will prescribe an antibiotic that some MRSA strains are susceptible to (for example, sulfamethoxazole and trimethoprim [Bactrim], linezolid [Zyvox], or clindamycin [Cleocin T]). Oral antibiotics may work for more invasive or severe infections, but many physicians prefer to treat them with IV antibiotics such vancomycin (Vancocin), sometimes in combination with another IV antibiotic. […] The majority of serious illnesses are treated with the help of an infectious disease expert.
  • #89 MRSA Tests: MedlinePlus Medical TestLock
    https://medlineplus.gov/lab-tests/mrsa-tests/
    A MRSA test looks for MRSA bacteria in a sample of fluid or tissue from your body. The sample is often taken from your nose or a wound. […] This test is most often used to find out if you have a MRSA infection. The test may also be used to see if treatment for a MRSA infection is working. […] You may need this test if you have symptoms of a MRSA infection. Your symptoms will depend on where the infection is located. […] A health care provider will take a fluid sample from your wound, nose, blood, or urine. […] After your test, your sample will be sent to a lab for a bacteria culture test. Most tests take 24-48 hours to get results. […] If your results are positive, it means you have a MRSA infection. Treatment will depend on how serious the infection is. […] To understand the results of a MRSA test, your provider will consider your symptoms, medical history, and the results of other tests.
  • #90 MRSA: diagnosis, screening and management – The Pharmaceutical Journal
    https://pharmaceutical-journal.com/article/ld/mrsa-diagnosis-screening-and-management
    Pharmacists should be able to undertake TDM to optimise a patient’s therapy to minimise the risk of adverse reactions. […] It is therefore important for healthcare professionals to understand the diagnosis, screening and management of MRSA-colonised and MRSA-infected patients, in combination with IPC guidance, and apply these to day-to-day practice.
  • #91 MRSA: Nursing Diagnoses, Care Plans, Assessment & Interventions | NurseTogether
    https://www.nursetogether.com/mrsa-nursing-diagnosis-care-plan/
    A standard diagnostic procedure to screen for MRSA colonization is DNA PCR of MRSA from the nares. […] Clinicians should send blood, sputum, urine, or wound samples suspected to be the source of infection for analysis. […] Patients suspected of having S. aureus bacteremia should undergo echocardiography or transesophageal echocardiography (TEE) to rule out endocarditis. […] If untreated or undertreated, MRSA can worsen into sepsis. […] If infection symptoms don’t improve within a few days of taking the prescribed antibiotic, advise the patient to call their healthcare provider. […] Patients at risk for MRSA infection (transfer from LTC facility/prison, invasive lines, immunosuppression) or with a history of MRSA should be screened for MRSA via nasal swabbing. […] Increasing WBC and neutrophil counts indicate bacterial infection. S. aureus appears as gram-positive cocci in clusters in gram staining. If cultures are inconclusive, DNA PCR is the gold standard and most sensitive test to identify MRSA.
  • #92 MRSA Surgical Site Infections: What You Should Know | bioMérieux Living Diagnostics Blog
    https://www.biomerieux.com/us/en/blog/infectious-diseases/MRSA-surgical-site-infections.html
    In low- and middle-income countries, 11% of patients who undergo surgery are infected in the process. […] However, with antimicrobial resistance on the rise, many infections are becoming more and more difficult to treat. MRSA, or methicillin-resistant Staphylococcus aureus, is a type of S. aureus that has become resistant to many first-line antibiotics and it commonly infects surgical wounds. […] The World Health Organization reports that patients with MRSA infections are 64% more likely to die than those with drug-sensitive infections. […] MRSA in healthcare settings can lead to a number of severe issues including surgical site infections, blood stream infections, sepsis, and even death. […] Overall, MRSA infections in hospitalized patients are declining, but they can still be difficult to treat. MRSA infections are preventable and many lives have been saved through effective infection control interventions. […] However, MRSA is resistant to currently-available beta-lactam antibiotics, which includes penicillins, such as amoxicillin, anti-staphylococcal penicillins, such as methicillin, and cephalosporins.
  • #93 Failure to Diagnose a MRSA Infection | Baltimore Medical Malpractice Lawyers
    https://www.arfaalawgroup.com/medical-negligence-and-personal-injury/medical-malpractice/failure-to-diagnose-or-treat-misdiagnosis/failure-to-diagnose-a-mrsa-infection/
    MRSA infections can be deadly, and a patients prognosis depends, in part, on the timeliness of their diagnosis. […] In most instances, laboratory tests are needed to determine if a person has MRSA or another infection. […] MRSA infections require urgent care, and delays can be fatal. Thus, people who suffer losses due to a doctors failure to diagnose a MRSA infection will often seek compensation in a medical malpractice lawsuit. […] The failure to diagnose a MRSA infection can have life-altering consequences.
  • #94 MRSA Surgical Site Infections: What You Should Know | bioMérieux Living Diagnostics Blog
    https://www.biomerieux.com/us/en/blog/infectious-diseases/MRSA-surgical-site-infections.html
    In low- and middle-income countries, 11% of patients who undergo surgery are infected in the process. […] However, with antimicrobial resistance on the rise, many infections are becoming more and more difficult to treat. MRSA, or methicillin-resistant Staphylococcus aureus, is a type of S. aureus that has become resistant to many first-line antibiotics and it commonly infects surgical wounds. […] The World Health Organization reports that patients with MRSA infections are 64% more likely to die than those with drug-sensitive infections. […] MRSA in healthcare settings can lead to a number of severe issues including surgical site infections, blood stream infections, sepsis, and even death. […] Overall, MRSA infections in hospitalized patients are declining, but they can still be difficult to treat. MRSA infections are preventable and many lives have been saved through effective infection control interventions. […] However, MRSA is resistant to currently-available beta-lactam antibiotics, which includes penicillins, such as amoxicillin, anti-staphylococcal penicillins, such as methicillin, and cephalosporins.
  • #95 Methicillin Resistant Staphylococcus aureus Culture Screen | Test Detail | Quest Diagnostics
    https://testdirectory.questdiagnostics.com/test/test-detail/90417/methicillin-resistant-staphylococcus-aureus-culture-screen?p=r&cc=MASTER
    Methicillin Resistant Staphylococcus aureus Culture Screen – MRSA is a major cause of nosocomial and life threatening infections. Infections with MRSA have been associated with a significantly high morbidity, mortality and cost. Selection of these organisms has been greatest in the healthcare setting. However, MRSA has also become more prevalent in the community. To control the transmission of MRSA, the Society for Healthcare Epidemiology of America (SHEA) has recommended guidelines, which include an active surveillance to identify potential reservoirs and a rigorous infection control program to control the spread of MRSA. […] Methodology: Chrom Agar method […] Reference Range(s): No Methicillin Resistant Staphylococcus aureus (MRSA) isolated. […] Preferred Specimen(s): Nasal swab […] Alternative Specimen(s): Specimens from skin surfaces „non-wound” (i.e. axilla, perianal and groin)
  • #96 Methicillin-resistant Staphylococcus aureus (MRSA) | Disease Outbreak Control Division
    https://health.hawaii.gov/docd/disease_listing/methicillin-resistant-staphylococcus-aureus-mrsa/
    Methicillin-resistant Staphylococcus aureus (MRSA) is caused by staph bacteria that are resistant to common antibiotics, such as penicillin and amoxicillin. […] In order to diagnose a MRSA infection, a small skin or open wound discharge sample is needed to perform a laboratory culture. Collecting the bacteria for the culture is a procedure usually done by a doctor or nurse. […] Clinicians play a critical role in slowing the spread of MRSA. Rapidly identifying patients colonized or infected with these organisms and placing them on strict Infection Control Precautions when appropriate, using antibiotics wisely, and minimizing invasive device usage are all important parts of preventing MRSA transmission.
  • #97 MRSA infection – Symptoms & causes – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/mrsa/symptoms-causes/syc-20375336
    It’s usually spread by skin-to-skin contact. […] If wounds appear infected or are accompanied by a fever, see your doctor. […] MRSA infections can resist the effects of many common antibiotics, so they’re more difficult to treat. […] This can allow the infections to spread and sometimes become life-threatening. […] In the hospital, people who are infected or colonized with MRSA often are placed in isolation as a measure to prevent the spread of MRSA. […] They also must follow strict hand hygiene procedures. […] For example, health care workers can help prevent HA-MRSA by washing their hands with soap and water or using hand sanitizer before and after each clinical appointment. […] Hospital rooms, surfaces and equipment, as well as laundry items, need to be properly disinfected and cleaned regularly.
  • #98 Methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus aureus (SA)
    https://diagnostics.roche.com/global/en/article-listing/health-topics/infectious-diseases/mrsa.html
    Prompt diagnosis and treatment are of utmost importance. […] The substantial human suffering and financial burden of these endemic infections prompt an urgent need for healthcare facilities to establish effective surveillance for infection control and prevention. […] To address the evolving problem of MRSA/SA, growing numbers of hospitals are partnering with microbiology labs to incorporate MRSA/SA screening and surveillance to identify and control these infections. […] Microbiology labs are the first lines of defence for detection of MRSA/SA unexpected outbreaks. By implementing a reliable surveillance program that rapidly and accurately detects colonised patients, clinical microbiology and infection control can help reduce the worldwide burden and spread of these costly infections.
  • #99 Laboratory Testing for Methicillin (oxacillin)-resistant Staphylococcus aureus (MRSA) | MRSA | CDC
    https://www.cdc.gov/mrsa/php/laboratories/index.html
    There are many methods laboratorians can use to test for MRSA. […] Four phenotypic methods are recommended for the detection of MRSA. […] Accurate detection of oxacillin/methicillin resistance can be difficult due to the presence of two subpopulations (one susceptible and one resistant) that may coexist within a culture of staphylococci. […] Isolates that test positive for mecA or PBP2a or resistant by any of the recommended phenotypic methods should be reported as methicillin (oxacillin) resistant. […] Phenotypic methods recommended for the detection of MRSA include: Cefoxitin broth microdilution, Oxacillin broth microdilution, Cefoxitin disk diffusion testing. […] A screening agar containing 6 g/ml of oxacillin in Mueller-Hinton agar supplemented with NaCl (4% w/v; 0.68 mol/L) is an alternative method of testing for MRSA.
  • #100 Laboratory Testing for Methicillin (oxacillin)-resistant Staphylococcus aureus (MRSA) | MRSA | CDC
    https://www.cdc.gov/mrsa/php/laboratories/index.html
    There are many methods laboratorians can use to test for MRSA. […] Four phenotypic methods are recommended for the detection of MRSA. […] Accurate detection of oxacillin/methicillin resistance can be difficult due to the presence of two subpopulations (one susceptible and one resistant) that may coexist within a culture of staphylococci. […] Isolates that test positive for mecA or PBP2a or resistant by any of the recommended phenotypic methods should be reported as methicillin (oxacillin) resistant. […] Phenotypic methods recommended for the detection of MRSA include: Cefoxitin broth microdilution, Oxacillin broth microdilution, Cefoxitin disk diffusion testing. […] A screening agar containing 6 g/ml of oxacillin in Mueller-Hinton agar supplemented with NaCl (4% w/v; 0.68 mol/L) is an alternative method of testing for MRSA.
  • #101 MRSA infection – Diagnosis & treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/mrsa/diagnosis-treatment/drc-20375340
    Doctors diagnose methicillin-resistant Staphylococcus aureus (MRSA) by checking a tissue sample or nasal secretions for signs of drug-resistant bacteria. The sample is sent to a lab where it’s placed in a dish of nutrients that encourage bacterial growth. […] But because it takes about 48 hours for the bacteria to grow, newer tests that can detect staph DNA in a matter of hours are now becoming more widely available. […] During your physical exam, your doctor will closely examine any skin cuts you may have. He or she might take a sample of tissue or liquid from the cuts for testing.
  • #102 Current molecular approach for diagnosis of MRSA: a meta-narrative review
    https://pmc.ncbi.nlm.nih.gov/articles/PMC9906022/
    A total of 20 studies were included in this synthesis: seven studies employed polymerase chain reaction (PCR) for diagnosing MRSA, one study employed deoxyribonucleic acid (DNA) Microarray, two studies used DNA sequencing, Xpert MRSA/SA BC assay, matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF), multilocus sequence typing (MLST), GENECUBE and staphylococcal cassette chromosome mec (SCCmec) typing. […] PCR approaches have been commonly used for the effective diagnosis of MRSA, and the rapid emergence of MRSA has led to a series of PCR approaches that have been developed for the identification of MRSA. […] Recent researchers have also cited the use of the PCR approach for mecA gene detection as the gold standard method for the detection and identification of the prevalence of MRSA.
  • #103 Methicillin-resistant Staphylococcus aureus (MRSA) – Symptoms, diagnosis and treatment | BMJ Best Practice
    https://bestpractice.bmj.com/topics/en-gb/910
    MRSA is an important cause of infection in both healthy people in the community and in patients in healthcare institutions. […] It is important to distinguish MRSA colonisation from infection. […] Healthcare-associated MRSA infections and community-associated MRSA infections exhibit important differences in antibiotic susceptibility. […] Community-associated MRSA most commonly results in skin and soft-tissue infections and therapy can often be with oral antibiotics. […] Healthcare-associated MRSA infections usually require treatment with intravenous antibiotics. […] Isolation of patients with MRSA, through contact precautions, may help to prevent spread of infection. […] MRSA infections can include syndromes of bacteraemia, pneumonia, endocarditis, joint infections, and skin or soft-tissue infections.
  • #104 2 Lab Tests you Must Demand: MRSA Survivors & a Scientist
    https://infectioncontrol.tips/2016/01/11/2labtests-mrsa/
    I suggest getting it right the first time. […] But, they should still immediately follow up with a laboratory confirmation, period. Otherwise, the diagnosis is a guess, at best. […] I often tell my students (future medical laboratorians and nurses), family, and the general public that if you do nothing else when a physician or other healthcare worker prescribes you an antibiotic empirically or tells you its just a regular staph infection, be sure to DEMAND a culture/ID and antibiotic susceptibility test. It just may save your life or that of a loved one!
  • #105 Diagnosing Staphylococcal Infections | NYU Langone Health
    https://nyulangone.org/conditions/staphylococcal-infections/diagnosis
    To diagnose a staphylococcal, or staph, infection, your NYU Langone doctor takes a medical history and performs a physical exam. […] A test can also be used to determine whether youre infected with methicillin-resistant Staphylococcus aureus (MRSA), a type of staph thats resistant to common antibiotics. […] A test is used to tell the doctor which medications the organism is resistant to and which antibiotics would be most effective. It can help your doctor choose the medication best able to fight the staph infection.
  • #106 MRSA Diagnosis and Treatment: Antibiotics, Drainage, and More
    https://www.webmd.com/skin-problems-and-treatments/understanding-mrsa-detection-treatment
    Often skin infections caused by MRSA are diagnosed clinically, without any tests. […] If tests are run, they will likely do a culture of an open sore for MRSA. […] A blood culture may be taken to look for bacteria.
  • #107 Current molecular approach for diagnosis of MRSA: a meta-narrative review
    https://pmc.ncbi.nlm.nih.gov/articles/PMC9906022/
    The study by Senok and colleagues (2021) also reported that DNA microarray exhibited 100% specificity and sensitivity. […] Xpert MRSA/SA Blood Culture is an in vitro diagnostic test for S. aureus and MRSA. […] A study by Reddy and colleagues has shown the performance of the Xpert MRSA/SA BC assay to be 100% in specificity and sensitivity. […] MALDI-TOF mass spectrometry (MS) has become a widely used technique for the rapid and accurate identification of bacteria. […] MLST is a technique that distinguishes between isolates of bacteria species by utilizing sequences of internal fragment house-keeping genes. […] This meta-narrative review reports the commonly used molecular methods for the detection of MRSA in the past 5 years. […] In this review, multiple molecular methods such as PCR, DNA sequencing, Xpert MRSA/SA BC array, MALDI-TOF, MLST, SPA typing and SCCmec typing, have been appraised. This review summarizes that PCR technique has been widely used for the diagnosis of MRSA within the last 5 years (2017-2022). […] This meta-narrative review has appraised and summarized molecular diagnostic methods frequently used to detect MRSA in the last 5 years (2017-2022), thus concluding that PCR technique is the most frequently used technique due to its high specificity, low cost and labor effectiveness.
  • #108 Methicillin-resistant Staphylococcus aureus (MRSA) | Disease Outbreak Control Division
    https://health.hawaii.gov/docd/disease_listing/methicillin-resistant-staphylococcus-aureus-mrsa/
    Methicillin-resistant Staphylococcus aureus (MRSA) is caused by staph bacteria that are resistant to common antibiotics, such as penicillin and amoxicillin. […] In order to diagnose a MRSA infection, a small skin or open wound discharge sample is needed to perform a laboratory culture. Collecting the bacteria for the culture is a procedure usually done by a doctor or nurse. […] Clinicians play a critical role in slowing the spread of MRSA. Rapidly identifying patients colonized or infected with these organisms and placing them on strict Infection Control Precautions when appropriate, using antibiotics wisely, and minimizing invasive device usage are all important parts of preventing MRSA transmission.
  • #109 2 Lab Tests you Must Demand: MRSA Survivors & a Scientist
    https://infectioncontrol.tips/2016/01/11/2labtests-mrsa/
    A MRSA diagnosis MUST BE based on A laboratory culture / Identification and antibiotic susceptibility testing! […] Current patient education programs about antibiotic resistant infections need to be revised. Particular attention should be paid to the following areas: b) the delivery of critical information about the importance of having a MRSA diagnosis based on laboratory culture and antibiotic susceptibility testing; […] Without a laboratory confirmed diagnosis, physicians or others are just guessing! […] These two tests a culture/ID and susceptibility test accurately identifies the bacterium that is causing the infection AND the correct antibiotic(s) one must prescribe to correctly treat the patient. […] If a physician or other uses an empirical, educated guess based on signs/symptoms or their gut feeling based on experience, they may be right. They could also be completely wrong.